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The pap smear test is highly effective at detecting pre-cancerous and cancerous cervical
cells. However, only 68.3 percent of women in the U.S. received a Pap smear in 2001. Previous
research studies have shown that overweight and obese women are less likely to receive routine
pap smears. This is especially concerning because obesity is a risk factor for cervical cancer-
Methods
A retrospective review of data was conducted from the medical records of 90 women, 18
years of age or older, who were seen by the researcher at SMDC clinics in Deer River and
Remer, Minnesota from February 2OO3 through May 2003.
Results
Bivariate analysis revealed an inverse trend between BMI levels and the prevalence of
pap smears. Women in the highest BMI level were the least likely to have received a Pap smear
(63-6To,n = l1). Overall, however, only 76.7 percent of all of the subjects had received a Pap
smea1 within in the past three years. There was, however, a strong, positive correlation between
Pap smears and physical exarns (Pearson's coefficient 0.716, p < 0.001).
Conclusions
The results revealed that the cervical cancer screening rates for the Deer River and Remer
clinics were well below the national goal (76.7Vo verses 90Vo). Even though obese women were
the least likely to have received a routine Pap smear, the correlation between Pap smears and
exams indicated that the providers at the Deer River and Remer clinics consistently performed
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BMI and the prevalence of Pap smears I
CHAPTER I: Introduction
B ac k g r o und I nfo rmat i on
preventive health care is a vital component for the maintenance of good health in all
women. According to Taber's Cyclopedic Medical Dictionary, preventive medicine is defined as
.,the anticipation and thwarting of disease in individuals and populations" (Venes,2001, p.
1750). preventive health care can be divided into three levels of care - primary, secondary and
tertiary. primary prevention includes health care services that are designed to prevent the onset
of a targeted disease or condition. An example of primary prevention is the Polio vaccine which
is used to prevent and eradicate the disease of Polio. Secondary prevention includes services that
are designed to identify individuals who have a disease or risk factors for a disease. An example
of secondary prevention is the Pap smear test which is used to screen women for cervical cancer'
Lastly, tertiary prevention includes services designed to treat and manage people with diseases.
An example of tertiary prevention is the reduction of total cholesterol in a woman with heart
disease (United States Preventive Services Task Force, 1995). While preventive health care
encompasses a vast affay of health care services, there are certain services women, who are l8
years of age and older, should obtain on a regular basis. For example, height measurement,
weight measurement, blood pressure reading, cholesterol blood test, blood glucose test, fecal
occult blood test, dental ex€ttn, vision exam, glaucoma test, hearing exam, physical exiun, clinical
breast exam, pelvic exam, digital rectal exam, mafilmography, sigmoidoscopy and Pap smear test
are many of the preventive health care services women should routinely receive (McKesson
Clinical Reference Systems, 2002)-
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However, not all women obtain the preventive health care services just previously listed.
Why do some women utilize preventive health care services while others do not? Based on
information from the federal government's Healthy People 2010, "patient barriers [to preventive
health care] include lack of knowledge, skepticism about the effectiveness of prevention, lack of
usual source of primary care, and lack of money to pay for preventive care" (Healthy People
2010, n.d., Chapter 1: Access to Quality Health Services, p. 3).
Besides the above mentioned barriers to preventive care, recent research has indicated
that women who are overweight or obese are less likely to obtain preventive health care services
than women who are average weight (Adams, et al., 1993,Fontaine, et aI.,2001, Fontaine, et al-,
lg9g, Lubitz, et a1., 1995, Olson, et al.,lg94 & Wee, et aL,2000). Moreover, results from a
research study examining the relationship between weight status and the prevalence of health
conditions indicated that women who are overweight or obese are at an increased risk for chronic
diseases like coronary heart disease, high cholesterol, high blood pressure and cancer (Must, et
al., 1999 &. Garfinkel, 1985).
Statement of the Problem
If a woman's weight can be a major barrier for her to seek preventive health care services
and excess weight can adversely affect her health, then it is important that this barrier be
identified and addressed by the medical community. Since preventive health care is so vast, this
study focused exclusively on cervical cancer screening with the Pap smear test. Thus, this
research project examined if a woman's body mass index affected the prevalence of her Pap
smear tests.
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Purpose oJ'the Study
The purpose of this research study was to exarnine if a relationship existed between a
woman's body size and the prevalence of her preventive care as indicated by the frequency of a
pap smear test. The study was conducted at the St. Mary's / Duluth Clinic sites in Deer River
and Remer, Minnesota. Each woman's body size was calculated and standardized using the
body mass index or BMI. BMI is a scientific measurement that incorporates height and weight
measurements to determine aperson's body size. Once each woman's BMI was calculated, a
BMI level was assigned. The BMI levels were based on guidelines from the National Institutes
of Health and included the following: underweight, average weight, overweight, obese I, obese II
and obese III. Due to the broad spectrum of preventive health care services, this research study
focused exclusively on Pap smear tests. Prevalence was measured by whether a woman had had
a Pap smear within the past three yearu.
Besides collecting data to determine BMI and the prevalence of Pap smears, the
researcher also collected additional information that could potentially influence a woman's
decision to seek preventive health care services. This information consisted of a woman's age,
marital status, smoking status and the gender of her health care provider. At the request of the
lnstitutional Review Board members from the St. Mary's / Duluth Clinic (SMDC), data
regarding the prevalence of complete physical exams was also collected. Similar to Pap smear
tests, the prevalence was measured by whether a woman had had a complete physical exam
within the past three Years.
The main objective of this research project was to determine if a relationship existed
between a woman's body mass index and the prevalence of her preventive care as indicated by
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the frequency of a Pap smear. In order to avoid recall errors an#or biases, data for this research
project was abstracted from the medical records for each subject. The rural sites of Deer River
and Remer were chosen primarily out of convenience by the researcher. The second objective of
this study was to identify variables that could influence a woman's decision to seek preventive
health care and potentially confound any association between a woman's BMI and the
prevalence of her preventive care.
Definitions of Important Concepts
The following terms were defined using MedicineNet.com.
Adenocarcinoma: A cancer that develops in the lining or inner surface of an organ.
Body mass index (BMI): An index used to determine an individual's body size by calculating
his/her weight in kilograms (kg) divided by his/trer height in meters (m) squared-
Carcinorna: Cancer that begins in the skin or in tissues that line or cover body organs.
Carcinoma in situ: Cancer that involves only the place in which it began and has not spread.
Carcinoma in situ is an early-stage tumor.
Cervical intraepithelial neoplasm (CIN): Dysplasia of the cervical cells. It is considered a pre-
cancerous condition of the lining of the cervix.
Cervix: The cervix is the most inferior portion and the narrowest part of the uterus (womb).
Colposcopy: A procedure in which a lighted magnifying instrument, called a colposcope, is used
to examine the tissues of the vagina and the cervix-
Endometrium: The mucous membrane that lines the uterus.
Glandular cells: A group of cells that selectively removes materials from the blood, concentrates
or alters them, and secretes them for further use in the body or for elimination from the
body.
Hysterectomy, radical: The surgical removal of the uterus, as well as the tissues near the uterus
(parametria and uterosacral ligaments), the upper portion of the vagina, and the pelvic
lymph nodes. The ovaries and fallopian tubes are usually left intact. It is most commonly
used to treat stage I and II cervical cancer.
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Hysterectomy, simple: The surgical removal of the uterus. It does not usually involve removing
any tissues near the uterus (such as the parametria and uterosacral ligarnents), the vagina,
the pelvic lymph nodes, the ovaries, or the fallopian tubes. The procedure is most
coillrnonly used to treat stage I cervical cancer, but it is also used to treat carcinoma in
situ or leiomyoma (uterine fibroids)-
lrradiation: The use of high-energy radiation from x-rays, gamma rays, neutrons, and other
sources to kill cancer cells and shrink tumors. Radiation may come from a source outside
the body, such as with external-beam radiation therapy, or from within the body using
materials called radioisotoPes.
Lymphadenectomy: Surgical rernoval of a lymph node.
Malignancy: A tumor or abnormal growth of tissue. A neoplasm may be benign or rnalignant-
Metrorrh agia: Iregular uterine bleeding that usually occurs between the anticipated menstrual
periods.
pap smear test (papanicolaou test): A screening test for cervical cancer based on the
examination of cells collected from the cervix.
pelvic examination: A physical examination of the organs of the female reproductive system.
An instrument called a speculum is used to open the vagina. The speculum allows the
walls of the vagina and the uterine cervix to be inspected. A sample of cells may be taken
off the surface of the cervix for a Pap smear or a sample may be obtained for laboratory
culture. The uterus womb and ovaries are felt with the fingers to detect swellings or other
abnormalities.
Postcoital Bleeding: Uterine bleeding after sexual intercourse.
pre-cancerous: Tissue that is that is not yet overtly cancerous, but appears to be progressing
towards becoming a cancer.
preventive health care: Health care that deals with methods of preventing the occurrence of
disease.
Sqamous cells: Flat cells that make up most of the cells in the outer layer of the skin, the
passages of the respiratory *rrd digestive tracts, and the linings of the hollow organs of
the body.
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Assumptions and Limitations of the Study
The limitations the researcher encountered during this study included 
a smaller than
estimated sample size, and an inability to collect data on the socioeconomic 
status of each
subject. Although previous research has shown the amount of 
education and income to be
influential factors in a woman's decision to seek preventive health 
care services, this information
could not be obtained from the medical records of the subjects 
at the Deer River and Remer
clinics. A smaller that anticipated sample size was another limitation- 
The sample size was
smaller than predicted for two reasons. The first reason was the fact 
that the researcher was a
physician assistant student and did not have unlimited access to the 
medical records at the Deer
River and Remer clinics. According to Minnesota statute 144.335, students 
are regarded as
..external researchers", and therefore their access to medical information is 
restricted' As a
result, the researcher was only granted access to the medical records 
of the patients whom were
seen in clinic-
With respect to the assumptions of this research project, the researcher assumed 
that lack
of health insurance would not be a barrier to any woman who needed 
of a Pap smear test, and
that race-related datawouldnot be an important variable in the study's 
findings. Based on
information from the 2000 Census, the population in the Deer River 
area was approximately 94'6
percent caucasian ,3.4percent American Indian,0.2 percent Black 
or African American,0'3
percent Asian or pacific Islande r, o.zpercent other, and 1.3 percent multiple 
race' Due to the
homogeneity of this population, it was assumed that race-related data would 
not be a statistically
significant finding in this study. As for lack of health insurance, the 
researcher assumed this
would not be a barrier because of the Minnesota Breast and cervical 
cancer control Program'
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This program provides free breast and cervical cancer screening to women who are either
uninsured or underinsured. Therefore, it was assumed that all women in this study would have
equal access to preventive health care services, like Pap smear tests, regardless of their health
insurance status.
Overttiew of Chapters
Chapter II will focus on pertinent literature concerning barriers to Pap smear tests, body
mass index (BMI), Pap smear testing, cervical cancer and previous research regarding BMI and
preventive health care. In Chapter III, the researcher's methodology will be discussed and
explained. Chapter IV will present the data collected and reveal the results from the statistical
analyses. Lastly, Chapter V will provide a surlmary of conclusions rnade from the results
revealed in Chapter IV, and will address recommendations for future research.
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CHAPTER II: Literature Review
Introduction and B ackground Info rmation
The importance of preventive health care can not be overemphasized. It is a vital
component in the maintenance of good health for all women. As explained earlier, preventive
health encompasses prevention, identification, treatment and management of a disease and/or its
risk factors.
A prime example of preventive health care for women is the screening of cervical cancer
with the Pap smear test. Overtime, the Pap smear has become the test of choice to screen for
cervical cancer. ln fact, it has proven to be such an effective screening tool, it has been
estimated that if all women would receive an annual Pap smear test, the incidence and mortality
of invasive cervical cancer would be reduced by 90 percent (Eddy, 1990). One source even went
so far as to predict that if all women would receive annual Pap smear tests, invasive cervical
cancer would be virtually nonexistent (Saksouk, 2003). The reality is, however, that only 68.3
percent of women in the United States obtained a Pap smear in 2001. This percent increased to
87.5 when a three-year Pap smear screening interval was considered (United States Department
of Health and Human Services,2OOS,November l9). Even though 87.5 percent seems like a
high percent for cervical cancer screening, it is still below the federal government's goal of 90
percent for women lB years of age or older over a three year time span (Healthy People 2010,
Chapter 3: Cancer, n.d.).
Predictors of Compliance to Pap Smears
Why are only 68.3 percent of women getting an annual Pap smear? A study published in
lggg by Simoes, Newschaffer, Hagdrup, et al. attempted to answer such a question. Their study
analyzed data from the 1994 Behavioral Risk Factor Surveillance survey and the 1994 Missouri
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Enhanced Survey in order to identify predictors of compliance to cervical cancer screening
guidelines. The researchers concluded that women who were compliant with their Pap smears
were rnore likely to be insured, younger than 50 years of age, African-American, compliant with
marnmograms and clinical breast exams, a high school graduate and in no financial distress.
These conclusions were based on the odds ratios of non-compliance with annual Pap smears after
adjusting for age, education, income, health coverage, cost, mafilmograms, clinical breast exams,
smoking, exercise and body mass index. Another study that researched predictors of compliance
to the recorrmended guidelines for Pap smear testing revealed that American and Canadian
women who had healthy lifestyles were more likely to have had a Pap srnear within the past two
years (Hofer and Katz,1996). Specifically, compliant women were found to be nonsmokers,
non-obese, wear seatbelts, and exercise regularly as compared to non-compliant women.
Moreover, the research revealed a dose-response relationship between each of the above healthy
behaviors and the prevalence of Pap smears. For each additional behavior, the odds of obtaining
a pap smear were found to increase by ?4 percent, even after adjustments for age, income, family
size, education and marital status were made.
Barriers to PaP Smears
Besides identifying predictors of compliance, a fair amount of research has been
conducted to identify specific barriers to Pap smear testing. Previous research has shown certain
barriers to be associated with increasing age, ethnic minority status, lack of knowledge about
cervical cancer and the screening recommendations, lack of access to health care, failure of the
provider to recornmend screening, fatalistic attitudes about cancer, inability to comprehend the
importance of screening in the absence of symptomatology and comrnunication barriers
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(Glasgow, Whitlock, Valanis and Vogt, 2000). However, three different research studies from
the United Kingdom discovered that one of the most prevalent barriers to Pap smear testing in
the U.K. was a woman's belief of embarrassment and anxiety during the procedure (Crombie, et
al., 1995, Orbell, et al., 1995 & Yu and Rymer, 1998). Results from the Orbell et al. study
revealed that as many as 73 percent of unscreened British women believed the Pap smear test
would cause embarrassment and anxiety as corrpared to only 3l and 36 percent of screened
British women. In the United States, one study found a direct correlation between a woman's
anxiety about the Pap smear test and embarrassment about her body size (Olson, Schumaker and
yawn, Igg4). The study's results revealed that T2percent of all the women surveyed had
delayed their annual physical exam and/or Pap smear because they were embarrassed about their
weight. If a woman's weight is an underlying cause of hernon-compliance to an annual Pap
smear test, this barrier to cervical cancer screening should be identified and addressed by the
medical community.
Body Mass Index (BMI)
Over the last few decades the average body size of Americans has dramatically changed.
The United States Department of Health and Human Services has estimated that 64.5 percent of
U.S. citizens were classified as overweight in 2000 as compared to 46 percent in 1981 (American
Obesity Association, 2OOZ). Currently, it is estimated that 44 million Americans are considered
obese which is an increase of T4percent since t99l (United States Department of Health and
Human Services, 2003, April 22). The U.S. Department of Health and Human Services regularly
gathers statistical information about the health of the nation, including body size, through the use
of the National Health and Nutrition Examination Survey or NHANES. ln the past, the
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I{HANES has collected information to determine the trends of the nation's body sizes by
categori zingthem into the following weight levels: underweight, average weight, overweight or
obese. It is important to note, however, that determining a body size and categorizing it into a
specific weight level is not possible unless both weight and height measurements are collected-
For example, just knowing a woman weighs 150 pounds does not provide enough information to
calculate her body size and categorize her weight. However, if you know her height is 5 feet I
inches, you can now calculate her body size and determine that her weight is considered average
in comparison to her height. Thus, by measuring a person's height and weight, one is able to
calculate his or her body size, and determine if he or she is considered'underweight, average
weight, overweight or obese-
The concept of estimating a person's body size by measuring the ratio of weight-to-
height was created by a 19th century mathematician named Lambert Adolphe Jacques Quetelet
(Galtagher et al., 1996). Even though Quetelet's weight-to-height ratio, otherwise known as
euetelet,s index, uses height as a component, the end result is not strongly 
correlated to height
(Keys, Fidanza, Karvonen, Kimura and Taylor, 1972). Therefore, the body sizes of tall
individuals are not erroneously overestimated and categorized as overweight, and the body sizes
of short individuals are not erroneously underestimated and categorized as underweight-
Because euetelet's index is not strongly correlated to height, the index remains constant 
among
individuals with varying heights but with similar builds. As a result, Quetelet's index has been
used to calculate body sizes for populations- The exact calculation of Quetelet's index is body
weight in kilograms divided by height in meters squared (kg/mz) (Garrow, andWebster, 1985)'
Today, Quetelet's index is referred to as body mass index or BMI'
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BMI levels for adults. The body mass index (BMI) is used today as a tool to calculate an
individual's body size and determine if he or she is considered underweight, average weight,
overweight or obese. In 1998, the National Institutes of Health (NIH) categorized an adult's
body mass index (BMI) into the following levels (Dickerson, 2001):
Description BMI {,kg/rn2)
Underweight < 18.5
Average 18.5 - 24-9
Overweight 25.0 - 29.9
Obese 30.0-34.9 l-moderate
35.0 - 39.9 II - severe
Extremely Obese > 40 III - very severe
The above BMI levels, however, ffie not arbitrary categories, but based on
epidemiological data regarding concomitant health risks. As a result, the validity of these levels
has been endorsed by the NIH's Expert Panel on the ldentification, Evaluation, and Treatment of
Overweight and Obesity in Adults (Dickerson, 2001)-
BMI limitations. Even though BMI is a quick and easy tool to measure body size, the
index appears to have some limitations in measuring body fatness or the amount of fat. Per cubic
centimeter, fat has been shown to weigh less than muscle. However, it has been suggested that
BMI is unable to measure the difference between fat tissue (adipose) and lean tissue (rnuscle). In
one study, BMI was found to measure the weight of fat tissue and lean tissue to equal degrees
(Garn, Leonard and Hawthorne, 1986). Because BMI does not take into account that muscle
weighs more than fat, individuals, such as body builders, who have a rnuch higher percentage of
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lean tissue than fat could potentially have inflated BMIs and be categorized erroneously as
overweight or obese.
The limitation of BMI in measuring body fatness has also been indicated with gender and
age differences. With respect to age, population-based research has shown that BMI increases
with each decade of life until the fifth or sixth decade, and then declines (Kuczarski, Flegal,
Campbell, et al., 1994). However, when comparing young and olderindividuals with similar
BMIs, various research has found older people to have a greater percentage of body weight as fat
(Gallagher, et al., lggl,Deurenberg, Weststrate and Seidell, I991, & Visser, Van den Heuvel
and Deurenberg, l9g4). The increase in BMI and higher percentage of body fat with age is
thought to be due to a decrease in physical activity, a change in hormone rnetabolism, a
malnutrition in protein-energy, as well as other unidentified factors (Evans, 1992)- Nevertheless,
older people with a higher percentage of body fat could potentially have deflated BMIs and be
categorized erroneously as underweight or average weight'
As with aEe,BMI appears to have similar limitations in measuring body fatness between
genders. It has been determined that "women have significantly greater amounts of total body
fat than do men for an equivalent BMI. .. [and] the difference in fatness between men and women
of similar BMI was substantial and maintained throughout all adult age groups" (Gallagher, et
al., Ig94,p,236). As a result, some organizations have adjusted the NIH's BMI levels to
account for the difference in body fat between men and women. Generally, the BMI levels for
women have been slightly lowered and slightly raised for men.
Despite these reported limitations, however, the National Center for Chronic Disease
prevention and Health Promotion recofirmends using the same BMI levels for all adults
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regardless of age or gender (United States Department of Health and Hurnan Services, 2002,
April 29). Therefore, an adult man or woman would be classified as underweight with a BMI <
1g.5, as average weight with a BMI 18.5 - 24.9, as overweight with a BMI 25.0 -29-9, or
classified as obese with a BMI Z 30.0 (see Appendix A for Adult BMI Chart)-
Even though some studies have reported some limitations with BMI as a measurement of
body fatness, one study compared its accuracy to skin-fold thickness testin8, as well as to
specialized laboratory tests that measure body fat via density, body water or total body
potassium. The study's results revealed that BMI measured body fatness in kilograms with
roughly the same amount of accuracy as the specializedlaboratory methods using density, body
water and total body potassium (Garrow and Webster, 1984). In addition, the study revealed that
in a clinical setting, BMI was a more accurate and useful measurement for body fatness than
skin-fold thickness testing. This finding was largely due to the fact that height and weight are
easily and accurately obtained in a clinical setting with simple equipment like a scale and tape
measure. Because of its ease of use and proven accuracy, BMI has become the most cofirmon
instrument used to calculate a person's body mass and determine his or her weight category (see
Appendix A for Adult BMI Chart).
BMI as a screening tool. Besides determining a patient's body mass and weight category
in a clinical setting, another important significance of the BMI is to screen and monitor the
health status of a population. Presently the United States government uses BMI as a tool to
identify and monitor certain health risks and nutritional disorders. In the United States, a healthy
BMI for an adult is estimated between 18.5 and24.9, and aBMI> 25.0 has been associated with
an increased risk of cardiovascular disease, diabetes, high blood pressure, osteoarthritis, sleep
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apnea, gall bladder disease and cancer (United States Department of Health and Human Services,
2A02, April 29).
ln Minnesota, data results from the 2001 Behavioral Risk Factor Surveillance Systern
from the U.S. Department of Health and Human Services survey revealed the single most
prevalent risk factor for cardiovascular disease and a cerebral vascular accident (CVA) was a
body mass index z 25-0. Minnesotans with a history of heart disease and/or stroke were
surveyed and the results revealed that 61.7 percent were categorized as overweight or obese-
Only 30 percent of those surveyed had high blood cholesterol, and only 22.3 percent had
hypertension. The results also revealed that only 22.l percent were current smokers and only 4.3
percent had diabetes (United States Department of Health and Human Services,7003, May 19)-
These statistics are significant because cardiovascular disease, cerebral vascular accident, and
cancer are the top three leading causes of death in Minnesota. Although cancer was the leading
cause of death, heart disease and strokes accounted for approximately 30 percent of the state's
deaths in 2000 (Minnesota Department of Health, 2002, December 3).
BMI levels in Minnesota. Besides revealing a correlation between a high BMI and heart
disease and cerebral vascular accidents, the Behavioral Risk Factor Surveillance System survey
also revealed dramatic weight changes in Minnesotans over the last decade. Similar to the
national trends, BMI levels in Minnesota have increased. Specifically, the results revealed that
the percentage of Minnesotans categorized as obese (BMIZ 30.0) increased from 10.2 percent in
lgg0 taZ1.Spercent in 2002. Moreover, the percentage of Minnesotans categorized as
overweight (BMI Z5.O -Zg.g) increased from 34.1percent in 1990 to 36.6 percent in 2002
(United States Department of Health and Human Services,2003, February 18). With the
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exception of Minnesotans who were between 50 and 64 years old, and already categorized as
overweight, the survey also revealed substantial increases in the percentages of overweight and
obese Minnesotans for all adult age groups (see Appendix B for Percentages of Overweight and
Obese Minnesotans Grouped by Age) (United States Department of Health and Human Services,
?113,February l9). Minnesota women, however, displayed the most dramatic weight changes
over the past decade. Based on the results from the survey, the percentage of Minnesota women
categorized as obese increased from 8"5 percent in 1990 to 20.8 percent in2OA2. In addition, the
percentage of Minnesota women categorized as overweight had increased from 24.3 percent in
1990 toZg.Zpercent in2OOZ (see Appendix C for Percentages of Overweight and Obese Women
in Minnesota) (United States Department of Health and Human Services,2003, February 18)-
Pap Smears
Unlike the rise in Minnesota's and the nation's body mass indexes (BMIs), the incidence
and mortality rates of cervical cancer in the United States have fallen. Based on an article from
the -lournat of Women's Health and Gender-Based Medicine:
In 1945,23 [out ofl 100,000 U.S. women developed invasive cervical cancer, and
14 [out o{l 100,000 U.S. women died of the disease. In 1955, 17 [out ofl 100,000
U.S. women developed invasive cervical cancer, and 9 [out ofl 100,000 died of
the disease. In 1975, 13 [out ofl 100,000 U.S. women developed invasive
cervical cancer, and 7 [out ofl 100,000 died from the disease. Finally, in 1995,
only 7,4 [out ofl 100,000 U.S. women developed invasive cervical cancer, and < 3
[our of] 100,000 died of the disease (seltzer, 2002, p. a$a).
The most recent data on cervical cancer in the United States, however, indicated that 7'6 out of
100,000 women developed invasive cervical cancerin 2000 and 2.8 out of 100,000 died of the
disease. According to the national statistics, Minnesota was shown to have one of the lowest
death rates of invasive cervical cancer in 2000. Only 1.8 out of 100,000 Minnesota women
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died of invasive cervical cancer in 2000 (United States Department of Health and Human
Services, 2003, November l2)-
pap smear procedure. The reason for such a dramatic decline in the incidence and
mortality of cervical cancer during the previous century was the implementation and widespread
use of the pap smear test. Dr. George Papanicolaou developed the test in the 1930s when
cervical cancer was a leading cause of death from cancer for women in America (Eddy, 1990 &
Seltzer, 2000). It was specifically designed to screen women for cervical cancer by collecting
and observing cervical cell samples. Presently, the Pap smear test is either performed as a one
step or two step procedure. The older two step procedure or conventional method includes
scraping epithelial cells from the outer portion of the cervix (ectocervix) with a wooden or
plasric spatula and then scraping epithelial cells from the inner portion of the cervix (endocervix)
with a..cervical brush" (P. Fontaine, 1998). Both specimens are smeared and preserved on a
microscope slide. The one step procedure or Thin-Prep Pup, approved by The Food and Drug
Administration in 1996, involves a "cervical broom" only. The specimen is placed in a vial of
liquid fixative for special processing that includes monolayering on a microscope slide (P-
Fontaine, 1998).
pap sme&r test analysis and classification using the Bethesda system. After the cervical
specimens have been collected, they are sent to a laboratory and analyzed under a microscope by
a cytotechnologist andlor pathologist. The Food and Drug Administration, however, has recently
approved the use of two different computerized methods to assist cytotechnologists and
pathologists in analyzing cervical cell specimens. The PAPNET and the AutoPap 300QC are re-
screening tools and developed to improve the accuracy of Pap smear analysis. They are
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presently available, but are not covered by all health insurances (United States Department of
Health and Human Services, 2002, July).
After each cervical specimen has been analyzed, it is classified using The Bethesda
System. The Bethesda System classifies cervical cell samples into one of four different
categories. They are as follows (American Association for Clinical Chemistry, 2002, August
)')\.
1. Negative for Intraepithelial Lesion or Malignancy
2. Other: Endometrial Cells Present in a V/omen Age 40 or More
3. Epithelial Cell Abnormalities
4. Other Malignancies
This classification system was first introduced in 1988, revised in 1991 and recently updated in
ZOOL It has been said that the 2001 version reflects the most current knowledge about the
biology of the Pap smear test and addresses new screening technologies (National Cancer
Institute,Z11Z,April 23). The 2001 Bethesda System is currently replacing the traditional five-
tiered squamous epithelial class system and the cervical intraepithelial neoplasia (CIN) system
(see Appendix D for Pap smear classification systems) (Minnesota Department of Health, 2001).
Interpretation of the Bethesda system. As for the interpretation of each of the above
Bethesda categories, the section entitled "Negative for Intraepithelial Lesion or Malignancy" is
the desired or normal result. Under this category, there are two subsections entitled "Other Non-
neoplastic Finding" and "Organisms". These subsections allow pathologists to report abnormal
findings, not related to the risk of cancer, but rather related to inflammation or infection.
Abnormal cell changes due to infections from viruses, bacteria and/or yeast are reported under
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the subsection entitled "Organisms", and the eKact microorganism is listed in this subsection-
Abnormal cell changes due to inflammation are reported under the subsection entitled 
"Other
Non-neoplastic Findings". This subsection has also been called "Benign Cellular Changes"-
The causes of inflammation are usually secondary to injury and often the result of sexual
intercourseZ4hours prior to the Pap smear test (see Appendix E for the Bethesda System 2001)
(Hussain and Vincent, 2003).
The section entitled "Other: Endometrial Cells Present in Women Age 40 or More" is
used to report cells from the uterus (endometrial cells) that have been abnormally identified 
in
the cervical sample. Even though endometrial cells pose no risk of cervical cancer, their
presence in the cervical sample signify a potential abnormality with the uterus, and further
testing of the uterine lining (endometrium) is warranted.
The category entitled "Epithelial Cell Abnormality" is used to report cell abnormalities
that are associated with the risk of cervical cancer. The cervix contains two types of epithelial
cells, squamous and glandular. Squamous cells are located at the most external portion of 
the
cervix, whereas glandular cells are located at the opening and at the canal of the uterus. As 
a
result, this category has two subsections that classify the risk of cancer. Squamous cell
abnormalities of the cervix are a much more comrnon finding than glandular abnormalities' 
The
risk of cervical cancer with squamous cell abnormalities are ranked and reported according to
malignancy. The following terms are used to report and rank the risk of malignaxcy with
squamous cell abnormalities in the cervical sample (see Appendix E for the Bethesda System
2001) (American Association for Clinical Chemistf), 2002):
l. Atypical Squamous Cells: Unknown Significance (ASC-US) or cannot exclude High
Grade Squamous Intraepithelial Lesion (HSIL) or high grade changes
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2. Low Grade Squamous Intraepithelial Lesion (LSL)
3. High Grade Squamous Inrraepitheliat Lesion (HSIL) with or without features
susPicious for malignancY
4. Squamous Cell Carcinoma
Similar to squamous cell abnormalities, glandular cell abnormalities of the cervix are 
also
ranked and reported according to the risk of malignancy. The following terms are used 
to report
and rank the risk of malignancy with glandular cell abnormalities in the cervical sample 
(see
Appendix E for rhe Berhesda System 2001) (American Association for Clinical Chemistry,
2OO2):
l. Atypical Cells: Not Orherwise Specified or of Undetermined Significance (AGUS)
Z. AtYPical Cells: Favor NeoPlasrn
3- Adenocarcinoma In Situ
4. Adenocarcinoma from endometrium (uterus), endocervical (cervix), extrauterine
(origin from outside the uterus or cervix) or the site cannot be determined based on
the cervical sample from the Pap smear
If a type of cancer other than glandular adenocarcinorna or primary squamous carcinoma
is identified on the cervical specimen, the category entitled "Other Malignancies" is used 
in the
reporting process.
In addition to categorizing the cervical cell samples from the Pap smear tests, The
Bethesda System, also interprets the quality of the specimen. Conditions that can affect 
the
quality of the sample include douching, tub bathing, menstruation, certain medications, or 
use of
vaginal creams, foams or suppositories 48 to 72 hours prior to the Pap smear test 
(United States
Department of Health and Human Services, 2002, July). If the quality of the specimen is
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deemed unsatisfactory, it is discarded and a new specimen is requested (see Appendix E for the
Bethesda System 2001). If the results reveal a cervical sample is unsatisfactory, another Pap
smear test is recommended within six to eight weeks-
Efficacy of the pap smear test. Over time the Pap smear test has proven to be highly
effective at reducing the incidence and mortality rates of cervical cancer. The effectiveness of
the pap smear test in identifying pre-cancerous or cancerous lesions is measured by its specificity
and sensitivity. Sensitivity is the probability that a person with a disease tests positive for that
disease. The sensitivity of the two step or conventional Pap smear test is 51 percent (Minnesota
Department of Health, 2001). Specificity is the probability that a person without a disease tests
negative for that disease. The specificity of the conventional Pap srnear test is 98 percent
(Minnesota Department of Health, 2001)-
Pap smear screening guidelines. Even though the Pap smear test has become the
standard screening tool for cervical cancer, there is some debate as to how often a woman should
be screened. In 1986, a study was conducted to compare the effect of different cervical
screening strategies on the cumulative incidence of invasive cervical cancer. The results of the
study revealed very little difference in the reduction rates of cervical cancer between annual Pap
smear testing (9l.2To cervical cancer reduction rate) and Pap smear testing every three years
(g3.1Vo cervical cancer reduction rate) (Eddy, 1990). However, if a woman were to be tested
every three years as compared to every year, the number of Pap smear tests she would have to
undergo in her lifetime would be reduced by practically 50 percent. The majority of medical
organizations tend to recommend the following: "annual screening with a Pap test and pelvic
examination in all women who are orhave been sexually active or who are 18 years and older-
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The frequency of the pap tests may be decreased at the 
discretion of the physician after two or
three consecutive normal tests" (Zoorob, Anderson, 
cefalu and sidani, 2001, p' 1104)' The
U.S. preventive Service Task Force currently recommends 
screening for cervical cancer at least
every three years for all women who have been sexually active 
and who have a cervix' Pap
smear testing should begin at the onset of sexual activity 
and continues throughout a woman's
lifetime, even after menopause. However, women who 
have had a hysterectomy in which both
the uterus and cervix has been removed do not require 
pap smear testing unless the hysterectomy
had to be performed because of pre-cancerous or cancerous 
cervical lesions (united states
Department of Health and Human services, 2003, octobet 
2)'
Evaluation and m(rnagement of abnormal pap smears- It 
is estimated that 50 million Pap
smear tests are performed annuaily in the united states 
(National cancer Institute,2oo2' April
23), and approximately 5 to l0 percent of these Pap smear tests 
are reported as abnormal (united
states Department of Health and Human services,2001, June)- 
The evaluation and management
of a woman with an abnormal 
pap smear is dependent on the Bethesda classification of her
cervical specimen. According to the American society 
for colposcopy and cervical Pathology'
a woman whose pap smear resurt indicates Atypical squamous 
cells of undetermined
significance (Ascus) can be managed with one of three options- The 
least aggressive option
includes performing a pap smear every 4 to 6 months until 
the results of at least tfuee
consecutive pap smears are normal. Thereafter, a woman may 
return to having an annual Pap
smear test. However, if any of the repeat Pap smear tests are found to 
be abnormal, a colposcopy
is advised. A colposcopy is an office procedure that provides 
a magnified view of the cervix and
is used when abnormal tissue needs to be excised for a biopsy- 
The excision of abnormal
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cervical tissue is also a form of treatment, and the removal of cervical cells inside the cervix is
referred to as endocervical curettage (ECC). The second management option for ASCUS is an
immediate colposcopy. This allows health care providers to view and collect the cervical cells in
order to determine if they are benign, pre-cancerous or cancerous. The third option involves
testing for the presence of the human papillomavirus (HPV). Exposure to the human
papillomavirus is estimated to be the single most important risk factor for developing cervical
cancer (P. Fontaine, 1998). Of the 70 different types of HPV, research has identitied twelve
different types that are most likely related to the development of high-grade pre-cancerous
lesions and invasive cervical cancer. The twelve types of HPV most Iikely associated with
cervical cancer are 16, 18, 31,33,39,45, 51, 52,56,58, 59 and 68 (Minnesota Department of
Health,2001)" If one of the above types of HPV is present, an immediate colposcopy with
endocervical curettage is recommended. Based on findings from the National Cancer Institute, a
diagnosis of Atypical Squamous Cells of Undetermined Significance (ASCIJS) is expected in no
more than 5 percent of all Pap smear tests. However, 60 to 80 percent of women diagnosed with
ASCUS will have mild dysplasia identified after a colposcopy is performed (Minnesota
Department of Health, 2001).
The management for a woman with Low-Grade Squamous Intraepithelial Lesion
(LGSIL) and High-Grade Squamous Intraepithelial Lesion (HGSIL) involves a colposcopy with
endocervical curettage (ECC) and a biopsy to rule out any significant underlying dysplasia. It is
estimated that up to 60 percent of women with LGSIL Pap smear results revert to normal without
any treatment, whereas up to 95 percent of women with HGSIL Pap smear results have high-
grade lesions on biopsy and require further treatment (Minnesota Department of Health,200l).
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Even though women diagnosed with Atypical Glandular Cells of Undetermined
Significance (AGUS) constitute less than one percent of all abnormal Pap smears, this finding
can be indicative of a pre-cancerous change or frank malignancy (Minnesota Department of
Health, 2001). Therefore, a colposcopy with endocervical curettage and a biopsy is mandatory
for all women who are diagnosed with AGUS from their Pap smear results. If the biopsy
confirms Atypical Glandutar Cells of Undetermined Significance, additional excisional or
ablative treatments are warranted, and close follow-up with frequent Pap smear tests is required-
When a woman's Pap smear indicates squarnous cell carcinoma or adenocarcinoma,
management usually requires the expertise of a gynecological oncologist. The mode of treatment
depends on the stage of the cervical cancer at the time of diagnosis-
Cervical Cancer
Cancer of the cervix is primarily a preventable disease. It is characterized by the onset of
pre-cancerous lesions that are slow growing and gradually progress in recognizable stages before
developing into invasive cancer. Epidemiological studies have shown pre-cancerous cervical
lesions are most often diagnosed among women in their twenties, whereas localized or
carcinoma in situ is often diagnosed in women between the ages of 30 and 39, and invasive
cervical cancer if often diagnosed in women older than 40 years of age (Brinton and Fraumeni,
19g6). The transformation of a pre-cancerous lesion to invasive cervical cancer usually occurs
over several years. One study that followed women with pre-cancerous cervical lesions found
that 40 percent of them actually regressed to normal after seven years, 48 percent still had a pre-
cancerous lesion, eleven percent progressed to carcinoma in situ, and one percent progressed to
invasive cervical cancer (Stern and Neely, 1963). Another study that followed a series of women
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with untreated carcinoma in situ found that 30 percent of these women developed invasive
carcinoma after l0 years and 80 percent developed invasive carcinoma after 30 years (Saksouk,
2003). However, progression of carcinoma in situ to invasive carcinoma is not always the case.
Another study that observed women with untreated carcinoma in situ over a mean interval of 5-2
years discovered 36 percent of them regressed to normal based on Pap smear or biopsy results-
This regression, however, was restricted to women aged less than 40 at the time of the initial Pap
smear (Kinlen and SPriggs, 1978)-
Due to the slow growth rate of cervical cancer, the disease process is usually reversible if
it is identified prior to progressing to invasive cancer. It has been stated that 92 percent of
women in the United States survive when cervical cancer is detected in its early stages (Darves,
2003). Nonetheless, invasive cervical cancer is the most cornmon genital malignancy in women
world-wide, and the third most common genital malignancy in women in the United States after
carcinoma of the endometrium and ovary (Saksouk, 2003). Per year, the number of new cases of
invasive cervical cancer worldwide is estimated to be at371,200 or 9.8 percent of all cancers. In
the United States, approximately 13,000 new cases of invasive cervical cancer were diagnosed in
ZOOZwhich accounted for about two percent of the total new cancer cases in women (Saksouk,
2003). In Minnesota, approximately 200 wornen develop cervical cancer and 50 die from the
disease each year (Minnesota Department of Health,Z}A2, Septembet I2).
Types of cervical cancer. For women who are initially diagnosed with cervical cancer,
squamous cell carcinoma is the most corrmon type of cervical cancer. It accounts for
approximately 85 to 90 percent of all diagnoses. Adenocarcinoma, on the other hand, accounts
for only l0 to 15 percent of all cervical cancers (P. Fontaine, 1998). Per the 13,000 new cases of
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cervical cancer diagnosed in the United States each year, it is estimated that more than half of
these women have never been screened or have not had a Pap smear within the past five years.
Approximately 4,100 women die from cervical cancer each year (Darves, 2003).
Various studies, however, have shown the effectiveness of the Pap smear test in reducing
the risk of death from cervical cancer. One study published in 1984, presented findings that
..screening on one occasion, irrespective of woman's age and time since the smear was taken,
reduced the risk of invasive cervical cancer to less than SOVo (RR=0+44), and of CIN [or cervical
intraepithelial neoplasial to about a quarter (RR=0t24)" (La Vecchia, et a1.,1984, p. 781)' A
longitudinat study that was conducted in Sweden observed changes in the tive-year survival rates
of wornen diagnosed with invasive cervical cancer after the country began population-based
screening with the pap srnear test. From 1960 - 1964 to 1980 - 1984, the results revealed a
substantial increase in the five-year survival rate of wornen with invasive cervical cancer.
Specifically, the five-year survival rate increased l9 percent in the 20 to 29 year old age group,
increased 14.4 percent in the 30 to 39 year old age group, and increased 9.3 percent in the 40 to
4g year old age group after the country began a nation-wide cervical cancer screening program
(Adami, et al., 1994).
Symptoms of cervical cancer. Based on numerous studies regarding the screening and
detection of cervical cancer, it is has been determined that Pap smear tests reduce the mortality
of invasive cervical cancer by identifying the disease at an earlier, and thus, more treatable stage'
Routine cervical screening is especially important because the majority of women with early
stages of cervical cancer, and approximately 20 percent of women with invasive cancer, are
asymptomatic (saksouk, 2003), In fact, cancerous changes of the cervix do not usually cause
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pain and are often not detected until a woman has had a pelvic exam and a Pap smear. However,
some women do experience symptoms, but this is commonly after the abnormal cervical cells
have become cancerous and have invaded nearby tissue. The most common symptom of cervical
cancer, and typically the first one, is abnormal vaginal bleeding. Specifically, postmenopausal
bleeding, irregular menses, heavy menstrual flow, painless metrorrhagia or postcoital bleeding
are all possible symptoms of cervical cancer (Garcia and Bi,2OOZ). Other symptoms include
malodorous vaginal dischar1e, vaginal discomfort and dysuria" Yet, symptoms such as pelvic
pain, constipation, hematuria, and leg edemacan also be suggestive of invasive cervical cancer
(Garcia and Bi, 2OOZ).
Treatment of pre-cancerous and cancerous cervical lesions. Since pre-cancerous and
cancerous lesions are most likely to originate in the region of the cervix called the transformation
zone, most treatment modalities are designed to target this region. The transformation zone is
the area of the cervix where the squamous cells and the colurnnar cells meet. Treatment
modalities for non-invasive cervical cancer include excisional techniques or ablative techniques.
Types of ablative techniques are laser and cryotherapy. Cryotherapy involves freezing the
transformation zone of the cervix by applying a metal probe cooled by a refrigerant such as
nitrous oxide. It is estimated that cryotherapy cures approximately 90 percent of low-grade
lesions that are less than three centimeters in diameter (Minnesota Department of Health,200l)-
Cryotherapy is only indicated for srnall, superficial lesions since the effects of freezing are
limited to just a few millimeters of tissue depth. Laser ablation, on the other hand, is indicated
for large lesions with extensive glandular involvement. It involves the use of a carbon dioxide
laser under the guidance of a colposcope for improved visualization of the cervix. Even though
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laser ablation vaporizes the transformation zone, it is not indicated for invasive cancer
(Minnesota Department of Health, 2001).
As for types of excisional techniques, they include conization and loop electrocautory
excision procedure (LEEP). The loop electrocautory excision procedure excises the
transformation zone by utilizing a wire loop and an electrical current. LEEP is an appropriate
procedure for all grades of dysplasia, but not appropriate if invasive cancer is suspected. When
the results of a colposcopy with ECC have been unsatisfactory or other techniques have failed to
identify the source of the cervical abnormality, conization is the procedure of choice.
Conization, by cold knife or laser, involves the removal of a cone of tissue from the
transformation zone or other areas of cervical abnormality. It is considered an altemative
treatment to a hysterectomy for young women with rnicro-invasive cervical cancer (Minnesota
Department of Health, 2001)'
Treatment modalities for invasive cervical cancer depend on the stage of the cervical
cancer at the time of diagnosis, and are under the auspices of a gynecological oncologist-
Common treatment options for locally invasive cervical cancer include simple hysterectomy,
radical hysterectomy with or without pelvic and periaortic lymph adenectomy, and/or radiation
therapy, and chemotherapy (Minnesota Department of Health, 2001).
Staging of cervical cancer. There are four stages of cervical cancer which were created
in l9g4 by the International Federation of Obstetricians and Gynecologists (FICO) (P. Fontaine,
lggS). The stages of cervical cancer a.re as follows (Janerich, et al-, 1995, p.792):
Stage I Carcinoma is confined to the cervix-
Stage IA Preclinical carcinomas of the cervix, diagnosed only by
Stage IB Lesions of greater dimensions than 5-mm depth of
invasion or horizontal than 7-mm.
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Stage II Carcinoma extends beyond the cervix but not into the
pelvic wall. [t involves the uppcr two-thirds of the
vaglna.
Stage IIA No obvious involvement.
Stage lIB involvement.
Stage III Carcinoma has extended onto the pelvic wall or
involves the lower third of the vagina. Also includes
all cases of is or nonfunctio
Stage IIIA No extension onto the pelvic wall, but involves lower
third of v na.
Stage IIIB Extension onto the pelvic wall or hydronephrosis or
Stage IV Carcinoma has extended beyond the true pelvis or has
clinicall involved the mucosa of the bladder or rectum.
prognosis of cervical cancer. Similar to the treatment of cervical cancer, the prognosis
depends on the stage of the disease. The five-year survival rate for stage I disease is
approximately 90 percent, for stage II it is 60 to 80 percent, for stage III it is estimated at 50
percent, and for stage IV it is approximately 30 percent (Garcia and BI,}OOZ)-
Risk f1ctors for cervical cancer. Women from all walks of life have been diagnosed with
cervical cancer. However, there are certain risk factors that put some women at a higher risk
than others. As discussed previously, it is now known that exposure to the human
papillomavirus (HPV) is estimated to be the single most important risk factor for developing
cervical cancer. Research has indicated that HPV produces proteins that inactivate the cervical
cells' tumor suppressor proteins, p53 and Rb, and cause the cervical cells to divide
uncontrollably (p. Fontaine, 1998). Since the human papillomavirus is a sexually transmitted
infection, a woman's risk of developing cervical cancer is increased with the more sexual
partners she has. Research has also revealed that women who began having sexual intercourse
before age 18, and whose partners also began having sexual intercourse at an early age and/or
have had many sexual partners are at an increased risk of developing cervical cancer (I'lational
Institute of Cancer,Z}O},September 16). Although it is not known how or why, the risk of
Obvious parametrial
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cervical cancer also increases with the number of cigarettes a woman smokes per day in addition
to the number of years she has smoked (National Institute of Cancer,}}AZ, September 16)-
Other risk factors that have been identified from epidemiological studies include lower
socioeconomic class, minority status - especially African American, Hispanic and American
Indian, early or multiple pregnancies, middte age, long term use of oral contraceptives, exposure
to diethylstilbestrol (DES), immunosuppression, dietary deficiencies in vitamin A, vitamin C,
and folic acid and obesity (Brinton and Fraumen, 1986 & Garfinkel, 1985)-
Body Mass Index and Cancer
While there has been to be a lot of media attention surrounding the association between
obesity and diseases like hypertension, heart disease and diabetes, the association between
obesity and cancer has been less publicized. However, in 1985, the results from a prospective
study conducted by the American Cancer Society examining cancer and obesity were
republished in the journal Annals af Internal Medicine. The study analyzed mortality ratios in
relation to overweight, cancer and other diseases in 750,000 men and womefl over 12 years. The
results revealed that "overweight men had significantly higher mortality ratios for colorectal and
prostate cancer; overweight wornen had rnuch higher rates for cancer of the endornetrium, gall
bladder, and cervix; and also significantly higher rates for ovary and breast cancer" (Garfinkel,
1gg5, p. l03a). With respect to cervical cancer, it was determined that the risk of death from
cervical cancer for an obese woman (BMI > 30.0) was almost doubled as compared to the risk
for an average weight woman (BMI 18.5 - 24.9) (Garf,rnkel, 1985). Moreover, it has been
estimated that obesity raises the risk of malignancy by approximately 16 percent (Schindler,
te91).
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How obesity increases the risk of cancer is still being debated. However, studies of obese
men and women have discovered an abnormal production and metabolism of androstenedione, a
pre-hormone to testosterone and estrogen. It has been speculated that increased levels of
androgens are directly related to an increase risk of cancer (Kirschner, Schneider, Ertel and
Worton, lgB2). For women, it is believed that the excessive amount of estrogen stimulates
estrogen-responsive target organs, like the cervix, and causes excessive growth that subsequently
leads to cancer (Kirschner et al., l gSZ). Thus, the pathophysiology relating obesity to cervical
cancer may involve excess levels of estrogen hormones.
Underweight women, on the other hand, have been found to have a slightly lower risk of
cancer (Mellemkjaeret a1.,2001), A Danish study that followed 2l5l female patients with
anorexia nervosa from 1970 until 1993 found that "the risk for breast cancer was slightly
reduced, on the basis of 7 observed and 8.7 expected cases, whereas the risk for cervical cancer
was reduced by 0.6 times on the basis of 2 cases" (Mellemkj aer et al., 2001 , p. t7 4). Since
women with anorexia neryosa were found to have a lower risk of cancer, the study's results
supported the hypothesis that a low-caloric diet can decrease tumor development in humans-
Body Mass Index and Pap Smear Studies
Since pap smear tests are the most effective tool for screening and detecting cervical
cancer, and women with higher body mass indexes are at a greater risk for developing cervical
cancer, it is important to examine the prevalence of Pap smears in women with higher body mass
indexes. previous studies that have examined the relationship between BMI and the prevalence
pap smear tests have concluded that overweight and obese women were more likely to delay
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being screened for cervical cancer (Adams, et al., 1993, Fontaine, et aI.,2001, Fontaine, et al-,
1998, Olson, et al., 1994 & Wee, et al-, 2000)-
One of the first research studies to investigate a relationship between BMI and the
prevalence of pap smear tests was done in 1 989. Lubitz, Litzelman, Dittus and Tierney ( 1995)
conducted a study that examined if obese and morbidly obese women were less likely to receive
pap smear tests, and if physicians did not perform Pap smear tests based on womar's body size.
Data was obtained from l5 faculty and 7? resident physicians who saw 1,321 women in the
Regenstrief Health Center's General Medicine Practice in Indianapolis, Indiana. Specific
information was collected from a computer-generated reminder sheet that instructed the doctors
to write down whether a Pap srflear test had been performed during a subject's visit- The
physician could choose one of the following four responses: "(1) the Pap smear was done today;
(2) the pap smear reminder was not applicable because the physician felt the patient was too old
or a terminal illness precluded the need for testing; (3) the patient refused the Pap smear because
of lack of time, discomfort, fear, or a belief that it was unnecessaryl or (4) the physician delayed
the procedure until the next visit because of patient acute illness, vaginitis, menstruation or lack
of physician tirne" (p. 492). In addition to the predetermined categories, a separate space was
provided under each category for an open-ended response. The results from the physicians'
responses revealed no significant difference when nonperformance and performance of Pap
smear tests were compared to a woman's body mass index. "Pap smear performance wasZLVI
for non-obese women, 20Vo for obese women, and ZAVo for morbidly obese women (P = NS)-
After adjusting for age and race, odds ratios for omission of Pap smear was 1.20 for both obese
(g17o CI,0.86 - 1.67;P = NS) and morbidly obese women{95Vo CI,0.58 -2-47; P = NS)" (p.
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491). However, when the odds ratios for physicians' reasons for Pap smear nonperformance
were compared to body mass index and adjusted for age and race, the results revealed a
statistical dose-response relationship between increasing BMI and acute illness, vaginitis or
menstruation as the most frequentresponse. "The odds ratio was 1.73 with a95To confidence
interval,0.B4 -3.57,for obese women, whereas the odds ratio was 4.59 with a95% confidence
interval, 1.67 - lZ.5,for morbidly obese women" (Lubilz,Lilzelman, Dittus and Tierney, 1995,
p- ae$.
Even though, the results did not support the hypothesis that obese women were less likely
to receive pap smear tests or that physicians were less likely to perform Pap smears on obese
women, the results did reveal an interesting dose-response relationship between increasing BMI
and delayed pap smears due to acute illness, vaginitis or menstruation, One of the strengths of
this study was the large sarnple size of 1,521 physicians' responses. This improved the
researchers' statistical analyses and allowed them to detect smaller differences with greater
accruacy. A weakness of this study was the lack of data regarding a patient's income, insurance
and education status which are all believed to potentially influence a woman's decision to obtain
preventive health care. Another weakness of this study was the lack of terms such as "obesity"
or ..poor body image" listed as options for nonperforrnance on the reminder sheet- Lastly, the
study's sample population was primarily composed of low-incorne urban patients, zurd therefore,
the results of the study could notbe generalized to the U.S. population (Lubilz,Litzelman, Dittus
and Tierney, 1995).
A second study that examined the relationship between BMI and the prevalence of Pap
smear tests was published in 1993 in the journal of Women and Health by Adams, Smith, Wilbur
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and Grady. The focus of this study was whether patients' and physicians' attitudes about body
size impacted the prevalence of pelvic examinations. The study solicited female subjects
between the ages of 40 and 65 from newspaper advertisements with a statewide circulation in
Connecticut. From the 303 women that responded to the advertisements,29l surveys were
completed and returned. The study's survey entitled, The Women's Survey, collected the
following information: weight, height, date of birth, race, economic status, estrogen treatments
for menopause, how many pelvic exams within the past two years, their attifude of pelvic
examinations, and their opinion of their own appearance. As for data regarding physicians'
attitudes about body weight and pelvic examinations, a survey entitled, The Physicians' Survey,
was mailed to 3,095 Connecticut doctors specializing in Family Medicine and Internal Medicine-
From the surveys that were returned,1,316 were completed. The survey prompted physicians to
respond to the following statement: "I might be reluctant to perform a [pelvicJ examination
on...(l) very elderly; (2) very young; (3) very unattractive; (4) very attractive; (5) very thin; (6)
very obese; (7) poor in hygiene; (8) from a different ethnic background; (9) severely disabled;
(10) extremely reluctant" (pp.48 -49). The survey also collected information on each
physician's age, race, gender and specialty (Adams, Smith, Wilbur and Grady, 1993).
Result from The Physicians' Survey revealed that 83 percent of the doctors were reluctant
to perform a pelvic exam on a very reluctant patient and 53 percent of them were reluctant to
perforrn an exam on the very young. In addition, 37 percent of the physicians were reluctant to
perform an exam on a severely disabled patient, 22 percent were reluctant to perfortn an exam on
a patient with poor hygiene, and 17 percent of the physicians reported being reluctant to perform
a pelvic exam on a very obese patient. The youngest group of physicians expressed the most
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reluctance in examining a very obese patient at 21.0 percent as compared to the middle-aged
doctors at 15.4 percent or the older physicians at 14.4 percent. The results also revealed that
male physicians were more reluctant to examine the very reluctant patient at 86.6 percent as
compared to female physicians at75.7 percent. As for the results from The Women's Survey,
they indicated that wornen who were very overweight expressed more reluctance about the
pelvic examination. In addition, these women were less likely to have had an annual pelvic
exam within the last two years and were more negative about their own appearance as compared
to both average weight and overweight women (Adams, Smith, Wilbur and Grady, 1993),
One of the strengths of this study was that the data revealed a strong social component
between body weight and the prevalence of pelvic examinations. Another strength of this study
was that it collected data on each woman's socioeconomic status. However, a weakness of this
study was the highly self-selected sample of women and small representation of obese women.
Therefore, the findings of this study could not be generalized to the U.S. population. Another
weakness included the lack of definition for the terms "attractive" and "young" which might
have affected the validity of the physicians' responses. Lastly, bias an#or recall errors could
have been a factor since data on a woman's height and weight was self-reported in this study
(Adams, Srnith, Wilbur and Grady, 1993).
Another study that exarnined the relationship between a woman's BMI and the
prevalence of her pap smear tests was conducted by Wee, McCarthy, Davis and Phillips (2000).
In addition to pap smears, this study also examined the relationship between BMI and the
prevalence of mapmograms. Subjects were randomly selected from their responses to the 1994
National Health Interview Survey. The National Health Interview Survey is a self-reported
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survey that assesses the general health of the civilian, non-institutionalized U.S. population- The
Census Bureau for the National Center for Health Statistics oversees the National Health
lnterview Survey database. The study's research data was obtained from a supplemental survey
entitled year 2000 Supplement Survey. Wee et al. received 11,435 responses to their Year 2000
Supplement Survey. The survey specifically asked for the length of time since the woman's last
pap smear and maillmogram. In addition to receiving information on previous Pap smear and
mammogram dates, Wee et al. also obtained information on each woman's ethnicityhace, age,
marital status, education, annual income, type of insurance and region of the United States- The
above factors were included because they were considered to be influential factors in preventive
care, and thus possibly confounding variables in the analysis. The unadjusted result for BMI and
pap smears indicated that overweight and obese women (BMI l 25.0) were screened for cervical
cancer at significantly lower rates than women with average weights (787o comparedtoS4To)-
After the rates had been adjusted for age, race, insurance and socioeconomic status, the adjusted
rates were similar to the unadjusted rates. However, the relationship between BMI and Pap
smears in Caucasian and African American women did reveal a higher screening rate in African
Americans than in Caucasians. The strengths of this study were an 88 percent response rate and
the generalizability to women in the United States. Some of the limitations of the study were the
potential recall and/or bias errors from the self-reported data. Another limitation was the fact
that the researchers were unable to identify any comorbid conditions and/or risk factors for
cancer because of the cross-sectional design of the study ('Wee, McCarthy, Davis and Phillips,
2000).
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A fourth study to examine the relationship between BMI and the prevalence of Pap
smears was conducted by K.R. Fontaine, Faith, Allison and Cheskin (1998). In addition to BMI
and pap smear prevalence, the research study also examined the relationship between BMI and
the prevalence of breast examinations, mammograms, and gynecological examinations, as well
as the relationship between BMI and the frequency of physician visits. Subjects were randomly
selected from a sub-sample of adult female responders to the 1992 National Health Interview
Survey. The research data was obtained from a supplemental survey entitled The Cancer
Control Supplement Survey. The response rate to the supplemental survey was 6981. The
Cancer Control Supplement Survey specifically collected information'on the use of health care
services and on health-related knowledge and attitudes. In addition, various factors that were
believed to have an influential affect on the use of health care services were also identified- As a
result, information on age, race, family income, education, smoking status and health insurance
was also collected. After the above factors were adjusted, the data revealed that obese women
were significantly more likely than non-obese women to delay clinical breast examinations (odds
ratio 1.26,957o CI, 1.00- 1.58), gynecologic examinations (odds ratio 1.39, 95 Vo CI, l-15 -
l.6g),and Pap smear testing (odds ratio L.29,95Vo CI, 1.04 - 1.58). In addition, the adjusted
data supported a direct relationship between an increase in BMI and an increase in physician
visits. The results revealed a dose-response relationship between BMI and visits to a physician.
Specifically, for every one-unit increase in BMI, there was an average increase in physician
visits by a 0.063-unit. On the other hand, the study did not find any statistical corelation
between increase BMI and delay in mammography. The strengths of this study were an 87
percent response rate and the generalizability of the results to the U.S. population. Similar to
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previous studies, this study's limitations included recall andlor bias errors (K. R" Fontaine, Faith,
Allison and Cheskin, 1998).
In 1994, Olson, Schumaker and Yawn conducted a study that examined the relationship
between obese women and the prevalence of preventive health care including Pap smear tests- It
was an observational study that used a self-administered survey to nurses, nursing assistants,
health unit coordinators and general psychiatric assistants who were employed at a 250-bed
community hospital in La Crosse, Wisconsin. Three hundred and ten responses out of a potential
of 409 were returned. The survey asked for the respondent's height, weight, perception of body
weight, level of satisfaction with previous physician interaction regarding weight and whether a
medical appointment had ever been canceled due to weight concerns. In addition, data on age,
education and occupation was gathered because these were considered to be influential variables
for preventive health care. The results of the study identified that the most recent visit to the
physician was for a checkup or pelvic examination including a Pap smear. Based on the results,
o,nearly lSVo (n = 40) of all respondents, and 32To (n = 27) of those with a BMI in excess of 27
[or overweight], and55Vo (n = 6) of those with a BMI in excess of 35 [or obese] stated that they
had delayed or canceled physician appointments because they knew that they would be weighed"
(p. gg9). Seventy-two percent of women admitted they had delayed their office visit because
they were embarrassed about their weight, and alrnost 64 percent of the respondents explained
they had delayed their medical care because they wanted to lose weight before they saw their
physician. After adjusting the rates for age, education, weight perception and BMI, the data
indicated that only BMI was significantly correlated to canceling a doctor's appointrnent. They
reported that "similar models were tested for association with the date of the Papanicolaou smear
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and pelvic examination. Only the BMI proved to be statistically significantly associated with
delayed medical care. Time since the last pelvic examination increased with increasing BMI" (p.
gg0), One of the strengths of this study was the response rate of 76 percent. Another strength
was the study's ability to reveal some strong social and psychological influences that affect a
woman's decision to seekmedical care. Because this study's information was obtained from a
self-reported survey, limitations such as recall and/or bias errors were noted. Another limitation
was the fact that the population of this study was extremely homogeneous, and therefore the data
could not be generalized to the U.S. population (Olson, Schumaker, and Yawn, 1994)-
The most recent study that examined the relationship between'body mass index and the
prevalence of pap smear tests was published in November 2001. In addition to BMI and Pap
srnear prevalence, K. R. Fontaine, Moonseong and Allison also investigated the relation between
BMI and the prevalence of clinical breast examinations and mammograms. Another component
of the study was whether a woman's race had any affect on the relationship between BMI and
the prevalence of Pap smea.rs, clinical breast exams an#or marnmograms. The study was
conducted using secondary data obtained from the 1998 Behavioral Risk Factor Surveillance
Survey (BRFSS) datahase. This database is managed by the Centers for Disease Control and
prevention (CDC). At the time of the study, the database had over 80,000 responses from a wide
range of women and contained a "uniform, state-based data on preventive health practices and
risk behaviors that are linked to chronic diseases, injuries, and preventable infectious diseases in
non-institutionalized civilian adult populations aged 18 years and or older" (p. a6a). Additional
variables that were included in this study and considered potentially confounding were age,
marital status, education, annual income, srnoking status, employment status, health insurance
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and self-reported general health. After analyzing the data, the results indicated that obese
wornen were significantly more likely to delay a Pap smear test (odds ratio 1.34,957o CI, 1- 14 -
1.30), a clinical breast examination (odds ratio 1.19, 9SVICI, 1.08 - 1.30), and a mafirmography
(odds ratio 1.14, 95Vo CI, 1.02 * I.23) as compared to women who were average weight. In
addition, the results showed a correlation among BMI, clinical breast examinations and a
wornan's race. Specifically, the data suggested that overweight and obese Caucasian women
were more likely to delay clinical breast examinations than overweight and obese non-Caucasian
women (K. R. Fontaine, Moonseong and Allisoll, 2001).
Unlike previous studies that examined the relationship between BMI and Pap smear tests,
this study not only revealed a direct association between delayed Pap smears and obesity, but
also revealed a direct association between delayed Pap smears and underweight women.
.'Compared with women of desirable weight, underweight and overweight/obese women were
significantly more likely to delay Pap smear testing" (p. 468). One of the benefits of this study
was the use of a large, population-based database that contained a wide variety of women.
Therefore, the results of this study could be generalized to the U.S. population. One of the
limitations of this study was the likelihood of subject biases and/or recall errors. In addition,
only individuals with telephones could participate in the self-reported telephone survey- Another
limitation was the inability to test causal inferences between BMI and screening over time
because the study utilized a cross-sectional design. Lastly, the survey results were limited
because the data obtained from the BRFSS did not provide reasons as to why overweight and
obese women appear to delay cancer screening (K. R. Fontaine, Moonseong and Allison, 2001).
BMI and the prevalence of Pap smears 41
Conclusion
Since the 1950s, the Pap smear test has been the most effective screening tool for the
prevention and detection of cervical cancer. If detected early enough, cervical cancer is
preventable and treatable. As previous research studies have indicated, overweight and obese
women are less likely than average weight womsn to have a Pap smear test. This is especially
concerning because the mortality rates from cervical cancer have been estimated to be
significantly higher for overweight and obese women. Therefore, if an elevated BMI decreases
the likelihood that a woman will have a Pap smear test and increases the likelihood of mortality
from cervical cancer, then women who are overweight and obese should be educated about the
risks and encouraged to be screened for cervical cancer a with Pap smear test.
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CHAPTER III: Methodology
Introduction
For approximately 50 yeaJs the Pap smear test has been the most effective screening tool
for cervical cancer. If detected early enough, cervical cancer is preventable and treatable.
However, as previous research studies have indicated, overweight and obese women are less
likely than average weight women to have a Pap smear test. This is concerning because the
rnortality rates from cervical cancer have been estimated to be significantly higher for
overweight and obese women. As a result, if an elevated BMI decreases the likelihood that a
woman will have a Pap smear test and increases the likelihood of mortality from cervical cancer,
it is important to examine the prevalence of Pap smear tests in women with higher body mass
indexes. Thus, the purpose of this study is to examine the relationship between body mass index
and the prevalence of Pap smears.
Description of Methodology Selected
For this research project, a retrospective review of data from medical records was
conducted on women, l8 years of age and older, who were seen at the St. Mary's / Duluth Clinic
sites in Deer River and Remer, Minnesota from February 2003 through May 2003. A historical
method was ultimately chosen to avoid the recall errors and/or biases that were identified in
previous studies. Specific data was obtained from the patient's medical record, looking back no
further than three years. If the patient had not had a Pap smear within the last three years, data
was abstracted from the most recent visits. The specific information that was recorded included
the following: weight, height, z1e, gender of provider, marital status, smoking status, complete
physical exam within the previous three years, and Pap smear within the previous three years.
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No identifying information was recorded on the abstraction forms (see Appendix F for a copy of
the forms).
Design of the Study
The design of this study was correlational. The independent variable was body mass
index (BMI). This variable was derived by dividing a woman's weight in kilograms by her
height in meters squared (kg/mz). The web site
www.workoutsforwomen.com/body-mass-index.asp was used to calculate each woman's BMI
for this study. The dependent variables were prevalence of Pap smears and/or prevalence of
physical exams. potentially confounding or influential variables in this study were age, gender
of provider, smoking status and marital status. From the specific information that was recorded,
the following was identified as continuous data: weight, height, BMI and age; whereas the
following inforrnation was identified as nominal data: gender of provider, marital status,
smoking status, complete physical exam within the previous three years, and Pap smear within
the previous three Years.
Sample and Population
The researcher chose the female patient-population from the Deer River and Remer
clinics as the population for this study primarily out of convenience. Based on a telephone
conversation with the St. Mary's / Duluth Clinic's (SMDC) administrator, the number of patients
who were registered in 2003 with rnedical record numbers at the Deer River and Remer clinics
totaled approxirnately 6,000. Fifty percent were assumed to be women, and therefore the
approximate sample size for this srudy was estimated to be 3,000. Approval to collect data from
the medical records of female patients from the Deer River and Remer clinics was granted to the
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researcher on November 14,2002 from the chair of the Institutional Review Board at St. Mary's
/ Dulurh Clinic (see Appendix G for IRB approval from SMDC). Shortly thereafter, on
DecemberZ,ZOOZ.,the researcher gained approval and was issued the IRB number 2002-37-3
from the chair of the Institutional Review Board at Augsburg College (see Appendix H for IRB
approval from Augsburg College). However, ffi a graduate student, the researcher did not have
unlimited access to the medical records of the approximate 3,000 female patients- Per Minnesota
statute 144"335,the researcher's status as a student or "external researcher" significantly
restricted access to the medical records. As a result, the researcher was only granted access to
the medical records of the female patients seen at the Deer River and Remer clinics- Therefore,
data was collected from the medical records of adult women, 18 years of age or older, whom the
researcher saw at the Deer River or Remer clinic frorn February 2003 through May 2003-
Throughout that time, the researcher reviewed 162 medical records and abstracted complete data
from 90 medical records. Thus, the sample size of this research project was approximately three
percent of the female patient-population for the Deer River and Remer clinics during 2003-
Instrumentation
For this retrospective study, data was abstracted directly from the medical records of
women l8 years of age and older. Within each medical record, a woman's weight, height, date
of birth, provider's name, marital status, smoking status, Pap smear test result and physical
examination notation were typicatly present. The instrumentation used to gather the data
consisted of a pen and a form entitled Medical Record Data Collection (see Appendix F for a
copy of the forms).
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Data Collection and Other Prrtceclures
From February ZOO3 through May 2OO3, the researcher logged the medical record
numbers for each female patient seen at the Deer River and Remer clinics in a pocket notebook'
In total, the researcher obtained 162 medical record numbers. The medical record numbers were
initially entered chronologically into an Excel spreadsheet column. This column was eventually
copied and reorganized in numerical order. From these two columns, the researcher identified
any erroneously entered medical record numbers and removed any duplicated numbers- Since
the medical records in Deer River and Remer were not filed in numerical order, the researcher
used the column that was arranged numerically as a reference to pull and review the medical
records. The data that was collected from the medical records included the following: weight,
height, age, gender of provider, marital status, smoking status, complete physical exam within
the previous three years, and Pap smear within the previous three years. Data was obtained from
the patient's medical record, looking back no fuither than three years. If the patient had not had
a pap smear within the last three years, data was abstracted from the most recent visits. All data
was transcribed from the medical record onto the Medical Record Data Collection form (see
Appendix F for a copy of the forms). No identifying information was recorded on these
abstraction forms.
Data Analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences
(SpSS), version lZ.0 for Windows. Descriptive statistics were initiatly performed to determine
the means, ranges and frequencies for each of the variables. In addition, distribution curves were
established for the two continuous variables, age and BMI.
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The normalcy of each distribution curve was identified based on kurtosis and skewness
values. Skewness is the degree to which a distribution deviates horizontally from a noffnal bell-
shaped curve. The skewness of a standard or nornal distribution is zero. A positively skewed
distribution means that the majority of the scores are clustered at the lower end or left side of the
curve. As a result, the tail of the curve points toward the right (Portney and Watkins, 2000)-
Kurtosis, on the other hand, is the degree to which a distribution deviates vertically from a
normal bell-shaped curve. It is how peaked or flat a distribution is (Australian National
University, n.d.).
In order to identify variables that were significantly correlated'and expected to have
causal relationships, simple parametric and non-parametric correlation coefficient matrices were
performed. parametric statistics are used to estimate population parameters. In order to use
parametric tests, three assumptions must be rnet. First, it is assurned that the data is randomly
drawn and reflect the norrnal distribution of its parent population. Secondly, it is assumed that
the variances of the data are approximately equal, and thirdly, that the data is rneasured on
interval or ratio scales. Non-parametric tests are used when the above parametric requirements
are not met or when the sample size is small. It is also used when nominal or ordinal scales are
used (Portney and Watkins, 2000).
parametric and non-parametric correlational tests are also used to avoid Type I errors. A
Type I error occurs when a researcher erroneously concludes a significant correlation exists
between two variables, when in fact, the association was a result of chance or sampling error
(portney and Watkins, 2000). In this study, simple non-parametric correlation coefficient tests
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were used when analyzing BMI as a continuous variable due to its abnormal distribution curve,
and simple parametric correlation coefficient tests were used when analyzing age.
With respect to correlation coefficient tests, they are used to provide a quantitative
measure for a relationship between two variables. Correlation coefficient values range from
-1.00 to +1.00. The magnitude of the correlation coefficient indicates the strength of 
the
association between the two variables. The closer the value is to +1.00, the stronger the
association. The sign of the correlation coefficient indicates the direction of the relationship. In
a positive relationship, as the independent variable increases or decreases, the dependent variable
also increases or decreases. In a negative relationship, as the independent variable increases, the
dependent variable decreases, and vice versa (Portney and Watkins, 2000).
For this study, a Pearson's correlation coefficient or Pearson's r was used for parametric
correlations, and a Spearman's correlation coefficient or Spearman's p was used for non-
parametric correlations. The Spearman's correlation coefficient is a statistical test that
determines the magnitude and direction of the correlation between two ordinal variables.
pearson's r is a statistical test that determines the magnitude and direction of the correlation
between two interval or ratio variables (Portney and Watkins, 2000). For this study, the level of
significance was less than 0.05 and the statistical power was less than 0.20 for the Pearson's and
Spearman's correlation coefficient tests .
Based on the results of the Pearson's correlation coefficient tests, a T-test was used to
further analyze the relationship between age and gender of provider. A T-test is used to compare
two rneans, and is based not only on the relationship between the means of two variables, but
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also on their variances (Portney and Watkins, 2000). The level of significance for the T-test in
this study was less than 0.05-
Based on the results of the Spearman's and Pearson's correlation coefficient tests, Chi-
square tests were used to further analyze the relationship between Pap smears and BMI, marital
status and age, and physical exams and Pap smears. Chi-square is another statistical test that can
determine if a relationship exists between two variables. Chi-square tests are based on
comparisons of the frequencies or proportions observed and the frequencies or proportions that
are expected in the various categories (Portney and Watkins, 2000). In this study, the level of
significance for the Chi-squa-re tests was less than 0.05.
Due to a small expected frequency in the Pearson's Chi-square results, this study also
used the yates' correction for continuity test. The Yates' correction for continuity test adjusts
for small expected frequencies by reducing the size of Chi-square by subtracting 0.5 from the
absolute difference between the observed and the expected frequencies for each category before
squaring (Portney and Watkins, 2000). However, caution needs to be taken when using the
yates' correction for continuity because there is an increased chance of initially committing a
Type II error. A Type II error occurs when the statistical analysis is unable to document a
significant correlation between two variables, even though one exists. As a result, a researcher
will erroneously conclude no significant correlation exists between two variables (Portney and
Watkins, 2000). In this study, the statistical power was less than 0.20 and the level of
significance was less than 0.05 for the Yates' correction for continuity test-
Another bivariate statistical test used to identify significant relationships in this study was
odds ratios with 95Vo confidence intervals. The odds ratio test evaluates the strength to which
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the known independent variable increases or decreases the chance that the dependent variable
will occur(Portney and Watkins, 2000). ln this study, the odds ratio was considered to be
statistically significant if the confidence interval did not include the number 1-000 within its
range,
Based on the results from the odds ratios with 95Vo confidence intervals, final analyses
were performed using logistic regression. Logistic regression is a multivariable statistical test
that is used when the dependent variable is categorical. However, the independent variable(s)
can be continuous, ordinal or categorical. Logistic regression predicts the probability of the
dependent variable occurring in relation to the independent variable(s). Since the dependent
variable in a logistic regression test is the natural logarithm of the odds for the outcome, logistic
regression is used to adjust the odds ratios for any influential affect the other variables may have
on the outcome (Portney and Watkins, 2000). In this study, logistic regression was considered to
be statistically significant if the confidence interval did not include the number 1-000 within its
range
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CHAPTER W: Results
Demographics
Out of 162 medical records reviewed, g2 charts contained complete data. Two medical
records were discarded, however, because one patient was 16 years old and the other had a prior
hysterectomy. Therefore, data from 90 medical records was utilized in this study, which is three
percent of the female patient-population for the Deer River and Remer clinics-
Means and ranges for age, weight, height and BMI. From the 90 women whose
information was abstracted from medical records, the mean age was 43.6 years with a standard
deviation of 19.1. The women's ages ranged from 18 to 86 years. The mean weight was 179
pounds, with a standard deviation of 46.4pounds, and ranged from 101.5 to 308 pounds. With
respect to height, the mean and the mode were 64.6 inches, with a standard deviation of 2.6
inches. The women's height ranged from 58.5 to 69.5 inches. Lastly, the mean body mass index
(BMI) was 30.5 kilrrf, with a standard deviation of 8,9, and ranged from 17.5 to 60.3 k#*'.
Table 1
Means and Ranges for Age,Weight, Height and BMI









19. 1 18 - 86 years
101.5 - 308 pounds
58.6 - 69.5 inches
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Distribution curves for age and BMI. As for the distribution curves lor age and BMI,
BMI was nearly bimodal and had population spikes around 27 kglm2 and 32kglm?. Since BMI
did not have a normal distribution curve, non-parametric tests were used instead of parametric
tests when analyzing continuous BMI values. Frequency statistics revealed a skewness of 1-48 I
and kurtosis of 2.221.
Age, on the other hand, had a more normal distribution curve, but was slightly weighted toward
younger ages. Frequency statistics revealed a skewness of 0.531 and kurtosis of -0.749 for age"
The raw computation of kurtosis for the standard normal distribution is three. However, this
value is sometimes adjusted, as it was by the statistical package used for analysis of data in this
study, by subtracting three from the raw kurtosis value. As a result, the kurtosis of the standard
normal distribution was zero for this study-
Figure l: Body Mass Index Figure 2: Age in Years
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BMI levels. With respect to the various BMI levels, one woman was identified as
underweight, (BMI < 18.5),26 women were identified as average weight (BMI 18.5 - 24.9),26
wornen were identified as overweight (BMI 25.0 -29.9),19 women were identified as
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moderately obese or obese I (BMI 30.0 -34.9), seven women were identified as severely obese
or obese II (BMI 35.0 - 39.9) and eleven women were identified as very severely obese or obese
rII (BMI > 40.0).
























pap smears and physical exams. With respect to having a complete physical exam
within the past three years, it was discovered that 22.2 percent of the women (n = 20) had not
received a complete physical within the past three years, and 77.8 percent of the women (n = 70)
had received a complete physical within the past three years. Simitarl y, 23 .3 percent of the
women (n = 21) had not received a Pap smear test within the past three years, and763 percent of
the women (n = 69) had received a Pap smear test within the past three years-
I
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Figure 4: Percentage of Women and the Prevalence of Pap Smears and Physical Exams within
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Gender of provider. Considering the gender of the provider, 65.5 percent of the women
(n = 59) had the majority of their appointments with one of the four female health care providers
or had a female health care provider perform their physical exarn and/or Pap smear test within
the past three years. Exactly 34.4 percent of the 90 women (n = 3l) had the majority of their
appointments with one of the three male health care providers or had a male health care provider
perform their physical exulm and/or Pap smear test within the previous three years-
FigUre 5: Percentage of Female Patients Per Gender of Provider
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However, it is interesting to note that when the gender of the provider was analyzed with
a woman's age, T-test results revealed a statistical significance between the age differences of
patients seen by female providers and male providers. The results revealed the mean age of
patients for female providers was approximately 38 years with a standard deviation of 16.4 years.
The mean age of patients for male providers was approximately 58 years with a standard
deviation of Ig.7 years. The T-test value (t) equaled -4.111 with a957o confidence interval (C!
from -Z3.gZGto -8.297. The degrees of freedom (df) equaled 88, and the 2+ailed significance (p)
was less than 0.001 .







Patients Mean Age for
Fenrale Providers
Patient's Mean Age forMale
Providers
Marital status. As for marital status, 51.1 percent of the women (n = 46) were reported to
be married, and 48.9 percent of the women (n = 44) were reported to be not married. However,
when marital status was analyzed to the age levels, the results of the Pearson's Chi-square test
revealed a statistical significance. The results revealed16.7 percent of women who were
between the age range of 30 and 49 years were married; yet only 2O.7 percent of women younger
than 30, and 54.8 percent of women older than 50 years of age were married. The Chi-square
value was 18.754. The degrees of freedom (df) was 2 andthe two-sided significance (p) was less
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than 0.001 . As a result, the subjects of this study were more likely to be married if they were
middle-aged (between 30 and 49 years) verses less than 30 years or older than 50 years of age-
Figure 7: Percentage of Married Women by Age Range
2O.7Vo
54.\Vo
lTo Married <30 yrs old
a% Married 30-49 yrs old
ffi 7o M arried 50+ yrs old
l6.7To
Smoking status. Lastly, descriptive statistics revealed that 70 percent of the women 
(n =
63) were reported to be nonsmokers and 30 percent (n - 27) were reported to be smokers at the
time the data was abstracted from the medical records-
Bivartate Analyses for BMI and Pap Smear
Correlational tests. While the Pearson's and Spearman's correlation coefficient tests did
identify correlations between some variables, no statistical correlation was identified between
BMI and Pap smear with Spearman's p (see Appendix t).
Odds ratios. An unadjusted odds ratio with a95Vo confidence interval based on the
Woolf's method was calculated for Pap smears and the following four BMI categories:
l. <25.A (underweight and average weight) and 25.A -29.9 (overweight) and 30.0 +
obese I, II and III)
Z. <25.g(underweight and average weight) and 25.0 + (overweight and obese I, II and
m)
3. < 30.0 (underweight, average weight and overweight) and 30.0 + (obese I, II, and III)
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4. < 35.0 (underweight, average weight, overweight and obese I) and 35.0 + (obese II
and III)
The Woolf's method is a sirnple approximate method for calculating the conlidence intervals for
an odds ratio (Australian National University, n,d.). The results of this study, however, revealed
no statistical significance between Pap srnears and the above BMI categories (see Appendix J)"
Chi-square test. Chi-square is another statistical test that can determine if a relationship
exists between two variables. After Pap srnear frequencies were cross tabulated with BMI levels,
Chi-square tests revealed no statistical significance.
Table 2
Crosstabulation Between Pap Smear Frequencies and BMI Levels
BMI Levels To ofPap Smears within past 3 yrs To of Pap Smears not within past 3 yrs
< 18.5 100.07o O.OVo
r8.5 - 24.9 7 6.9Vo 23.tTo
25.0 - 29.9 80.87o 19.ZVo
30.0 - 34.9 78.9Vo 2L.l%o
35.0 - 39.9 71.47o 28.67o
40.0+ 63.67o 36.4To
Total 7 6.7 Vo 23.3Vo
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Table 3
Chi-Square Tests for Pap Smear Frequencies and BMI Levels




Number of valid cases
t.t 5l* 5 0.882
1.889 5 0.8&l
0.91 I 1 0.340
tFive cells (4 1.7 Vo) had expected frequencies less than 5. The minimum expected frequency is 0.23
Predictors of PaP Smears
Even though bivariate analyses did not reveal any statistical relationship between Pap
srnear and body rnass index, the Pearson's correlation coefficient test did reveal a statistically
significant positive correlation of 0.7 16 with p < 0.001 between the prevalence of Pap smears
and the prevalence of physical exams (see Appendix K). Crosstabulation between the frequency
of pap smears and physical exams revealed that 929 percent of women who had received a
physical exam within the past three years had also received a Pap smear. Only 7.1 percent of
women who had received a physical exam within the past three years had not received a Pap
smear within that same time frame-
90
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Figure B: percentage of Wornen who had a Physical Exam with and without a Pap Smear
7.lVo
HVo of Women with Exam and
Pap
lTo of Women with Exam and
without Pap
92.970
Based on the crosstabulation, the Pearson's Chi-square test revealed a statistical
significance between the prevalence of Pap smears and physical exams.
Table 4
Chi-Square Tests for Prevalence of Pap Smears and Physical Exams
Value df Asymp. Significance (2-sided)
Pearson Chi-square
Yates' Continuity Correction* *
Likelihood ratio
Linear-by-linear assoc.
Number of valid cases
46.158* I 0.000
47.17 5 l 0.000
4t.7 48 1 0.000
45.64s l 0.000
90
+One ce\l (25.07o) had an expected frequency less than 5. The minimum expected frequency is 4.67-
**Computed only for aZ x 2 table-
Since the expected frequency of one of the cells was small, the Yates' correction for
continuity test was performed. Even after the Pearson's Chi-square test was adjusted with the
yates' correction for continuity test, the results still revealed a statistical significance between
the prevalence of Pap smears and physical exams.
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An unadusted odds ratios based on the Woolf's method with a95To confidence interval
also indicated a statistically significant relationship between the prevalence of Pap smears and
physical exams (see Appendix J). However, when a logistic regression test was used to adjust
for the possible influences from the other variables, the odds ratio between Pap smears and
physical exams increased in strength from 52.000 (957o CI, 12.519 - 215-998, P ( 0.001) to
63.1 g7 {g|vo cI, 13.250 - 301.327, p < 0.001). Therefore, after the logistic regression test
adjusted for the covariates in this study, the results revealed a stronger association between the
prevalence of Pap smears and physical exams-
Table 5
Logistic Regression for Prevalence of Pap Smears and Physical Exams, Age [rvels (< 30, 30 -
a9 and 50 +), Marital Status, Smoking Status, Gender of Provider and Non-obese and Obese
BMI Levels








4.146 0.791 21 .06? I 0.000 63.187 13.250 - 301.327
0.391 2 0.823
-0.112 1 .093 0.025 1 0.875 0.842 0.099 - t .17 6
-o.sTs 0.935 0.383 1 0.536 0.560 0.090 - 3.503
0.01 I 0.836 0.000 I 0.990 1.01 I 0.196 - 5.208
0.824 0.872 0.893 I 0.345 2.280 0.413 - 12.597
provider's gender 0.669 0.852 0.616 I 0.432 1-953 0367 - 10'383
BMI levels 0.473 0.795 0.354 I 0.552 I .605 0.338 - 7.61 I
Constant 0.630 0.433 2.115 1 0. 146 t -877
tVariables entered on step l: physical exam, ages, married, smoker, provider's gender, BMI levels.
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Predictors of BMI
Even though correlational tests did not reveal a statistical significance between BMI and
pap smears, Spearman's p revealed apositive correlation between BMI and age (see Appendix
L). As a result, further analyses were done using BMI as the dependent variable and age as the
independent variable. BMI was categorized into two levels (obese or < 30.0 and non-obese or
30.0 +) and age was categorized into three levels (< 30, 30 - 49 and 50 +). The crosstabulation
between the frequency of obese women and non-obese women within the various age levels
revealed that2O; percent of obese women were younger than 30 years of age, 46.7 percent of
obese women were between the ages of 30 and 49, and 54.8 percent of obese women were older
than 50 years of age- Focusing exclusively on non-obese women, 79.3 percent were younger
than 30 years of age, 53.3 percent were between the ages of 30 and49, and 45.2 percent were
older than 50.
Figure 9: Percentage of Obese and Non-obese 













<30 yrs old 30-49 yrs old 50 + Yrs old
Based on the crosstabulation, the Pearson's Chi-square test results revealed a statistical
significance between increasing age and increasing BMI.
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Table 6
Chi-Square Tests for BMI Categories (< 30.0 or 30.0 +) and Age Levels (< 30, 30 - 49 and 50 +)










*No cells (O.1Vo) had expected frequencies less than 5. The minimum expected frequency is I 1.92-
In addition to the Pearson's Chi-square test, an odds ratio with a95% confidence interval
was calculated for BMI and age. Again, age was categorized into three levels (< 30, 30 - 49 and
50 +) and BMI was categorized into two levels (< 30.0 or non-obese and 30.0 + or obese)- The
results revealed a statistical significance between increasing age and increasing BMI.
Table 7
Odds Ratios for BMI Caregories (< 30.0 and 30.0 +) and Age Levels (< 30, 30 - 49 and 50 +)
B S.E. Wald df Sig. Exp(B) 95Vo CI for Exp(B)
Step l*: Age grouP 2
Age 30 - 49 1.210
Age 50 + 1.538
Constant -0.428
7.265 2 0.026
0.587 4.251 I 0.039 3.354 1.062-10.590
0.583 6.948 I 0.008 4.655 1.483 - 14.606
0.230 3.411 I 0.062
*Variable entered on step l: Age group 2
In order to account for any influences the other variables may have had on the association
between BMI and age, a multivariate analysis using logistic regression was done. When the
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model was adjusted for all of the covariates (marital status, smoking status, physical exam and
gender of provider), the estimated odds ratio between BMI and women aged 30 to 40 years
increased from 3.354 (95?o CI, l .062_ 10.590, P = 0.039) to 5'568 (957o CI, 1.403 _22,107, p =
0.0I5). In addition, the estirnated odds ratio between BMI and women aged 50 years and older
increased from 4.655 (95Vo CI, 1.483 * 14.606, p = 0.008) to8.228 (95Vo CI,2.175 -31.132,p=
0.002).
Table 8
Logistic Regression for Non-obese and Obese BMI Levels and Age Levels (< 30, 30 - 49 and 50
+), Marital Status, Smoking Status, Physical Exam Prevalence and Gender of Provider
B S.E. Wald df Sig. Exp(B) 95Vo CI for Exp(B)
Step I +: Age group 2








| .t l7 0.703 5.959 I 0.015 s.569 I .403 - Z2)O7
2.108 0.679 9.636 I 0.002 8.228 2.1'15 * 31 .132
-0.330 0.528 0.391 I 0.532 0.719 0.255-2-023
0.047 0.518 0.008 | 0.927 1.049 0.380-2.892
0.134 0.55 I 0.059 I 0.808 1 .144 0.388 - 3 -37 t
t.ozl 0.526 3.765 I 0.052 2.776 0-990 -7 -186
-0.573 0.304 3.549 1 0.060 0.564
*Variables entered on step 1: married, smoker, physical exam, provider's gender.
Trend Between Prevalence of Pap Smears and BMI Levels
Even though bivariate analyses with correlation coefficients, odds ratios and Chi-square
testing did not reveal any significance between BMI levels and the prevalence of Pap smears, a
trend was observed from the crosstabulation between these two variables (see Table 3)- Results
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revealed that as BMI levels increased, there was an overall down-going trend in the percentage
of women who had received a Pap smear within the last three years. Specifically, the
percentages of women who were compliant or had received a Pap smear within the last three
years were as follows: 100 percent were underweight, 76.9 percent were average weight,80.8
percent were overweight,78.9 percent were obese level I,71.4 percent were obese level II, and
63.6 percent were obese level III.

























In conclusion, because no statistical significanse could be established between the
prevalence of Pap smears and body mass index, the hypothesis that BMI affects the prevalence
of Pap smears could not be supported in this study-
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CHAPTER V: Discussion
Introduction
Based on the data collected from the medical records at the Deer River and Rerner clinics
for this research project, a trend was observed between BMI levels and the prevalence of Pap
smear tests. Even though no statistical significance was established between BMI and the
prevalence of Pap smears, bivariate analyses did reveal significant correlations between a
woman's age and her marital status, a woman's age and the gender of her health care provider, a
woman's age and her BMI level, and the prevalence of a woman's Pap smear test and the
prevalence of her physical examination.
Implications
pap Smears and Physical Examinations. Data from this study revealed a statistical
significance between the prevalence of Pap smears and the prevalence of physical exams- As
presented in Chapter IV, g2.g percent of women who had received aphysical exam had also
received a Pap smear. The unadjusted odds ratio indicated that women who had received a
physical exam were 52 times more likely to have also received a Pap smear than women who
had not received a physical exam (Woolf s 95Vo CI, 12.518 - 216.004, P = < 0.001). ln order to
account for any influential affects the other variables may have had on the correlation between
pap smears and physical exirrrrs, a logistic regression test was performed. After other variables
like BMI were included, the odds of a woman having received a physical exam and a Pap smear
actually increased. The adjusted odds ratio revealed that women who had received a physical
exam were 63 times more tikely to have also received a Pap smear. The importance of this
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finding, however, is that it indicated the health care providers at the Deer River and Remer
clinics were consistently performing Pap smears with physical examinations.
This is significant because there has been speculation about the possible negligence of
providers to perforn a Pap smear with a physical exarnination for certain women, especially
obese women. In fact, sorne health care providers have expressed concerns about the difficulties
they encounter when trying to obtain a cervical sample from an obese patient. The difficulty
occurs when excess abdominal tissue applies increased pressure on the vaginal walls- This
increased pressure causes the vaginal walls to collapse and obstructs the cervix (Penso, 1987).
As a result, it has been speculated that some providers are not performing Pap smears on obese
wornen because of the difficulty in obtaining cervical samples.
However, a study conducted in 1989 by Lubitzet al. specifically examined if physicians
were not performing Pap srnears based on a woman's body size. The results of the study
revealed no significant difference between performance and nonperformance of Pap smears
when comparing oyerweight and/or obese women to average weight women. Similar to the
Lubitz study, the findings of this study revealed that the health care providers at the Deer River
and Remer clinics performed Pap smears with physical examinations regardless of a woman's
body mass index.
Age and BMI Level. Another finding of this study was the statistical significance
between a woman's age and her BMI level. Crosstabulation between age and BMI categories
indicated a significant difference among the percentages of obese women who were 30 to 49
years old and at least 50 years old as compared to women who were younger than 30 years old.
The unadjusted odds ratios revealed that women between the ages of 30 and 49 years were
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approximately three and one half times more likely to be obese than those younger than 3A {95Vo
CI, I .062 - 10.590, p = 0.039). In addition, women 50 years of age and older were
approximately four and one half times rnore likely to be obese than women younger than 30
{g5To CI, I .483 * 14.606, p = 0.08). After the other variables were included and their potential
influence accounted for, the odds ratio actually increased in strength. The adjusted odds ratios
revealed that women between the ages of 30 and 49 years were approximately five and one half
times more likely to be obese than women younger than 3O (95Vo CI, 1 .403 -22.107, p = 0-015)'
Moreover, the adjusted odds ratios showed that women 50 years of age and older were roughly
eight times more likely to be obese than women younger than 30 (95% CI,2.175 -31.132,p=
0.002).
These findings are similar to data from the CDC regarding the incidence of obesity in
Minnesota. lnZ0O2, statistics revealed that 30.0 percent of Minnesota women between the ages
of 50 and 65 years were classified as obese as compared to only 16.4 percent between the ages of
lg and 34 years , or 24.6 percent between the ages of 35 and 49 years (United States Department
of Health and Human Services,z}[S,February 19). These statistics and the findings of this
study a5e consistent with various research that has shown as people age their percentage of body
fat increases (Gallagher, et al., 1994, Deurenberg, Westrate and Seidell, 1991 & Visser, Van den
Heuvel and Deurenberg, 1994)-
It is important to note that obesity and increased age are both risk factors for chronic and
Iife-threatening conditions like hypertension, hypercholesterolemia, diabetes and cancer
(Dickerson, Z00l & Garfinkel, 1985). However, unlike age, an elevated BMI is amodifiable
risk factor. Therefore, it is especially important that women maintain their weight as they age in
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order to control their risks for hypertension, hypercholesterolemia, diabetes and cancer. Since
this study revealed a positive correlation between increased age and increased BMI, the female
patients at the Deer River and Remer clinics should be educated about the importance of weight
maintenance with increasing age-
Age and Gender of provtder. A third finding of this study was the statistical significance
between a woman's age and the gender of her health care provider. Although approximately 66
percent of the patients had the majority of their appointments with a female provider, T-test
results indicated a statistical difference between the mean ages of women who were seen by the
female providers as compared to the male providers. The mean age of the patients seen by a
male provider was older (54.13 years), whereas the mean age of the patients seen by a female
provider was younger (38.07 years) (t = -4.1l l, 957o Cl, -23.826 - -8-297, p < 0.001).
The fact that the majority of the subjects were seen by a female provider for their
physical exam and Pap smear is consistent with previous studies that examined women's
preferences for the gender of their health care provider, A study published in The Western
Journal of Medicine revealed a significant difference in the number of women requesting a
fernale physician for gynecological concerns verses any other type of office visit (27Vo verses 
(
l6Ta,p < 0.001) (Engelman, Lg74). Another study that focused specifically on a woman's
preference for the gender of her gynecologist revealed that patients of female physicians and./or
female psychotherapist were significantly more tikely to prefer a female gynecologist verses a
male (5g.4To verses 9.8To,p < 0.001). In addition, the women who preferred female
gynecologists also believed that a female gynecologist would be more empathetic,
understanding, respectful and gentle with an examination (Haar, Halitsky and Stricker, 1975).
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Another reason why the majority of patients in this study saw a female provider,
however, could have been because there were more female providers than male providers. At
the time the data was collected, the Deer River and Remer clinics had four full-time female
providers, two full-time male providers, and one part-time male provider. Of the four female
health care professionals, one was a physician, one was a nurse practitioner and two were
physician assistants. All three of the male health care professionals were physicians-
The fact that all of the male providers were physicians may help explain why the mean
age of their patients was significantly higher. Based on the observations of the researcher, the
physicians tended to see more complicated patients as compared to the nurse practitioner or
physician assistants. According to the textbook Physician Assistant: Guide to Clinical Practice,
even though pAs in a family practice setting are able to manage 80 to 90 percent of the patients,
they are advised to consult with a physician if the patient's problem is complicated or rare
(White and Herlihy, 1999). In addition to complexity, it was the researcher's observation that
the patients who were seen by the physicians were older and often had multiple chronic
conditions. These observations are consistent with studies that have identified age as a risk
factor for chronic diseases like hypertension, hypercholesterolemia and diabetes (Dickerson,
2001). Based on the results of this study, the significant difference between a woman's age and
the gender of the provider is a logical finding once the past medical history of the patient and the
professional training of the provider are taken into consideration.
Age and Marital Status. Another finding of this study was the significance between a
woman's age and her marital status. Even though a little more than half of the research subjects
were rnarried, Chi-square test results revealed a significant difference between age levels and
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marital status. Approximately 77 percent of the wornen who were between 30 and 49 years ol'd
were married, as compared to only 24 percent who were younger than 30, or 55 percent who
were at least 50 years old (Chi-square = 18.754, df = 2,p <0.001). These results are consistent
with national and state-wide statistics on age and marital status. Based on national data from the
U. S. Census Bureau for the year 2000, 6'7.1 percent of women between 30 and 59 years old were
married, as compared to only I2.3 percent of women 15 to29 years old, or 20 percent of women
at least 60 years old (United States Census Bureau, American Fact Finder, Sex by Marital Status
by Age for the population l5 Years and Over, United States, n.d.). Data specific to Minnesota
for the year 2000 revealed that 69.5 percent of women between 30 and 59 years old were
married, as compared to only I 1. I percent of women 15 to 29 years old, or 19.4 percent of
women at least 60 years of age (United States Census Bureau, American Fact Finder, Sex by
Marital Status by Age for the Population 15 Years and Over, Minnesota, n.d-). The significance
between a woman's age and her marital status seems logical since younger women are usually
single, middle-aged women a.re often married or remarried, and older women are typically
widowed or divorced.
Trend Between BMI and Pap Smears. Even though no statistical correlation was
established between the prevalence of Pap smears and the various BMI levels, a trend was
observed between these two variables (see Chapter IV, Figure 10). Crosstabulation between Pap
smear frequencies and BMI levels revealed that the percentage of women who had received a
pap smear within the last three years eventually decreased as BMI levels increased. Women
with the highest BMI (> 40.0) or rhose classified as obese III were the least likely to have
received a pap smear within the past three years (63.6To,n = 1l). Women who were classified as
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underweight (BMI < 18.5) were the most likely to have received a Pap smear within the past
three years (100.07o, n = 1). However, this statistic is misleading because one underweight
woman participated in this study. On the other hand, when the percentages of average weight
(BMI 19.5 - Z4.g),overweighr (BMI Z5.A-29.9) and obese I (BMI 30.0 -34.9) women were
compared, the data revealed that overweight women (80.87o, n -26) and obese I women(78-9Vo,
n = 19) were slightly more likely to have received a Pap smear within the past three years than
average weight women (76.9Vo,n -26). These unexpected findings are most likely the result of
this study's disproportionate and relatively small sample size.
Regardless, the results of this study did reveal that the percentdges of women in all BMI
levels, except < 18.5 (underweight), did not meet the federal government's guidelines for
cervical cancer screening. Per Healthy People 2010, 90 percent of women who are sexually
active and/or at least l8 years of age should have at least one Pap smear test within a three year
time period (Healthy People 2010, n.d., Chapter 3: Cancer). Based on data from the Deer River
and Remer clinics, women who were classified as obese III (BMI > 40.0) were the least likely to
comply with the federal government's guideline. Only 63.6 percent (n = 11) of women with
BMIs over 40.0 had received a Pap smear within the past three years, This finding was similar to
results from previous studies that revealed an inverse relationship between a woman's body mass
index and the prevalence of her Pap smear tests. Per the six studies that examined the
relationship between BMI and Pap smears, only one did not identify a statistical significance
between an increasing body mass index and a decreasing prevalence of Pap smear testing-
Although data from the Lubitz et al. study could not support the hypothesis that obese women
are less likely to receive Pap smears, the results did reveal a dose-response relationship between
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increasing BMIs and delayed Pap smears due to acute illness, vaginitis or menstruation (Lubitz,
Litzelman, Ditters, and Tierney, 1995). A study conducted in 1994by Olson, Schumaker and
yawn, however, not only revealed a significance between an increase in BMI levels and a
decrease in the prevalence of Pap smears, but identitied that overweight and obese women
delayed their Pap smears because they were embarrassed about their weight. Another study
conducted by Adams, Smith, Wilbur and Grady identified that obese women were rnore negative
about their body images and more reluctant to have a pelvic exam and Pap smear test- In
addition, that study revealed that 83 percent of the physicians in the study were reluctant to
perform a pelvic exam and Pap smear on a reluctant patient, whereas i7 percent stated they were
reluctant to perform an exam and Pap on an obese woman (1993). Since obese women were
more reluctant about having an exam and Pap smear, and the majority of physicians admitted to
being reluctant about perforrning an exam and Pap smear on a reluctant patient, many obese
patients probably did not receive an exam or Pap smear because of their reluctance verses their
body size. Despite the reasons surrounding Pap smears and BMI levels, multiple studies have
discovered that overweight and obese women are not being screened for cervical cancer as often
as women who are average weight.
One study, however, identified a statistical significance between underweight women and
the prevalence of Pap smear testing. The study was conducted in 2001 by Fontaine, Moonseong
and Allison, and revealed a direct relationship between delayed Pap smears and underweight
women. "Compared with women of desirable weight, underweight and overweight/obese
women were significantly more likely to delay Pap smear testing" (2001, p.468). Although the
data from the Deer River and Remer clinics did not reveal any significance or trend between
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underweight women and Pap smear testing, one subject out of 90 was classified as underweight-
As a result of this study's disproportionate and small sample size, no statistical significance
could be established between these two variables-
Limitations
The primary limitation of this study was its small sample size. Ninety female subjects
could be included in this study. Although this represented approximately three percent of the
sample population, the number of women in each BMI level was disproportionately distributed.
One woman was classified as underweight, 26 were classified as average weight, 26 were
classified as overweight, 19 were classified as obese I, seven were classified as obese II and
eleven women were classified as obese III (see Chapter fV, Figure 3). Had the sample size been
larger, perhaps the number of women in each BMI level would have been more equally
distributed, and a statistical significance between BMI levels and the prevalence of Pap smears
could have been established.
As a student, however, the researcher was limited to the amount of data that was able to
be collected. Per Minnesota statue L44.335, students are regarded as "extemal researchers" and
do not have unlimited access to medical information like "internal researchers" or employees.
Therefore, the researcher was only granted access to the medical information of the patients seen
at the Deer River and Remer clinics.
While the researcher's status as a student limited the number of medical records that were
reviewed, the lack of height measurements documented in the medical records was another
limitation. Even though 162 medical records were reviewed, 92 records had height
measurements recorded in them. In addition, many of these measurements were actually height
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approximations given by the patients and recorded in the charts by the researcher. Thus, the lack
of height measurements docurnented in each medical record, as well as the researcher's status as
a student, severely limited the study's sample size.
Another limitation of this study was the inability to generalize the results to larger and
rnore diverse patientpopulations. Because the St. Mary's / Duluth Clinic sites at Deer River and
Rerner were chosen primarily out of convenience, the researcher was aware that the results
would be generalizable only to other rural health care settings with similar dernographics- As a
result, the statistical significance between Pap smears and physical exams, BMI and age, gender
of provider and age, and marital status and age could only be extrapolated to patient populations
that are rural, primarily Caucasian and contain only a few thousand female patients-
Discussion
The fact that this study revealed a strong and positive correlation between physical
examinations and pap smears indicated that health care providers at the Deer River and Remer
clinics were consistently perforrning Pap smears with physical examinations. This is important
because it implies that providers did not intentionally avoid performing Pap smears, based on
women's body mass indexes.
However, the fact that 23.3 percent of the subjects in this study had not received a Pap
smear within the past three years revealed that these patients had either not been reminded about
a routine exam and pap smear or had ignored attempts to remind them. During this fifteen week
study, the researcher often observed how health care providers at the Deer River and Remer
clinics verbally reminded their patients about the importance of a regular physical exam and Pap
smear. These verbal notices, however, were the only rerninders these female patients received.
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At the tirne of this study, the Deer River and Remer clinics did not mail any notifications to their
female patients to remind them about the importance of routine physical exams and Pap smears.
Even though this study indicated that 76.7 percent of the subjects from Deer River and Remer
had received a Pap smear within the past three years, this is still considerably lower than the
federal government's goal of 90 percent. As a result, improvements could be made in how these
women are rerninded about routine physical examinations and Pap smears. Perhaps written
notifications, as well as verbal reminders, would help improve the compliance of physical exams
and pap smears. In addition, providing information about the financial assistance from the
Minnesota Breast and Cervical Cancer Control Program (MBCCCP) for physical exams, Pap
smears and mammograms might also improve the compliance of patients who are uninsured.
However, before concerns about compliance could be addressed, barriers to Pap smear
testing needed to be identified at the Deer River and Remer clinics. Since the results of this
study indicated that women classified as obese II (35.0 - 39.9) and obese III (l 40.0) were the
least likely to have had a Pap srnear within the past three years (7l.4Vo and 63.67o, respsctively),
women at these BMI levels should be strongly encouraged by their health care providers, as well
as receive written notices reminding thern to schedule a physical exam and Pap smear- In
addition, information about MBCCCP's financial assistance should be provided to these women'
Besides the trend between obesity and non-compliance to Pap smear testing, the results of
this study revealed that women who were obese were also signifrcantly older (54-8To for > 50
years old, 46.77o between 30 and 49 years old, and 20.77o for < 30 years old). Moreover, it was
an observation of the researcher that a number of these older and obese patients also had chronic
conditions like cardiovascular disease, diabetes and osteoarthritis. As a result, some of these
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patients were seen by their health care provider on a routine basis to receive follow-up care for
their chronic illnesses. Even though these women were seen in the clinic regularly, they were
also part of the group that had the highest non-compliance for Pap smears. Perhaps these women
believed that a physical exam and Pap smear was not necessary since they were seen by their
health care provider so frequently. On the other hand, perhaps the health care providers believed
that the risk of cervical cancer for these patients was low enough to extend their screening
intervals beyond the standard three years. Unfortunately, specific reasons why older and obese
patients were less likely to have had a Pap smear within the past three years were beyond the
scope of this studY.
Bias
Unlike previous studies that obtained height and weight data directly from their research
subjects, this study collected height and weight data from the patients' medical records. It was
the researcher's intent to obtain this data from accurate and standardized measuring devices, and
as a result, avoid any recall errors and/or biases. However, the large number of height
measurements that were absent from many of the medical records was unforeseen- As a result,
the researcher began recording height measurements based on estimations from the patients.
Although the researcher attempted to code these height estimates by encircling them in the
charts, they were not tallied on the abstraction forms. Thus, the exact impact of any recall elrors
and/or biases on body mass index for this study was unknown-
Recommendations
Since women often underestimate their weight and overestimate their height, future
research should avoid these biases and recall errors by obtaining height and weight information
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directly from medical records rather than personal surveys. As a result, the body mass indexes
would be more accurate because the weight and height measurements would be from
standard izedrneasuring devices instead of from subjective personal recollections.
While previous research has indicated a correlation between a woman's BMI and the
prevalence of her Pap smears, only two studies have attempted to identify reasons why obese
women were less likely to receive a Pap smear. In the Olson et al. study and the Adams et al-
study, overweight and obese women were found to delay their Pap smear tests because they were
embarrassed about their weight and reluctant about the test (1994 and 1993). However, the
Adams et al. study also revealed that physicians were less likely to perform a Pap smear on a
reluctant patient.
Certain professionals, however, have offered their opinions as to why obese women are
less likely to be screened for cervical cancer. For example, some health care providers have
found it difficult to obtain cervical samples from obese patients. The difficulty occurs because
excess abdominal tissue applies pressure to the vaginal walls. The increased pressure causes the
vaginal walls to collapse and obstructs the cervix. As a result, some physicians have avoided
performing pap smears on obese women because of the difficulty in obtaining cervical sarnples
(penso, lgBT). However, it has been documented that obese women often avoid preventive ca-re,
like pap smears, because of the disrespect and disdain they receive from their physicians- In one
study, I3.Z percent of women with a mean BMI of 35.2 (obese If) reported that physicians made
critical and insulting comments about their weight at least sometimes, whereas 225 percent
reported that they were treated with disrespect because of their weight at least some of the time
(National Task Force on rhe Prevention and Treatment of Obesity, 2002). Other opinions as to
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why obese women avoid preventive health care inclucle lack of compassion and understanding
by office and medical stafl lack of privacy when weighing patients, lack of a differential
diagnosis by inappropriately assuming most conditions are obesity related, and lack of
appropriate equipment such as armless chairs in the waiting rooms, wide examining tables, and
appropriately-sized examination gowns and blood pressure cuffs (Zelitch-Yanovski, 1998)- In
fact, the National Association to Advance Fat Acceptance has stated that "many fat patients
avoid seeking preventive health care...because they either assume they will get another lecture
on weight loss or that accofirmodations will not meet their special needs" (NAAFA, n'd-).
Regardless of whether health care providers or obese women are responsible for the lack
of pap smear testing, future research needs to address the reasons why obese women are not
receiving routine PaP smears-
Conclusion
Even though this study did not attempt to identify any reasons why obese women were
less likely to receive routine Pap smears, the strong correlation between physical examinations
and pap smears (OR =63.187; g5To CI, 13.25 - 301 .327) indicated that the health care providers
at the Deer River and Remer clinics did not intentionally avoid performing Pap smears on
women who were obese. Based on the results of this study, a trend between BMI levels and the
prevalence of pap smears was observed. Specifically, the findings of this study revealed that
women who were severely obese (BMI 35.0 - 39.9) and very severely obese (BMI Z 40.0) were
rhe least likely to have had a Pap smear within the past three years (1 l.4%o and 63.6Vo). Overall,
however, the results revealed that only 76.7 percent of all of the subjects had received a Pap
smear within the past three years. This percent is considerably below the national goal of 90
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percent. Other significant findings from this study included correlations between obesity and
age, age and marital status, and age and gender of provider. Specifically, the results revealed
that obese women were more likely to be older, {54.8Vo were > 50 years old,46.7Vo we-ra
between 30 and 49 years old, and 2O.7To were < 30 years old), that middle-aged women were
more likely to be married (7 6.7 To between 30 and 49 years old, 54.8 Vo >- 5O years old, and 2O -7 Vo
< 30 years old), and that younger women were more likely to have had a female health care
provider for their physical exam and Pap smear (38.07 years old with female providers, and
54.13 years old with male providers)-
While the Pap smear test is presently the most effective means to prevent and detect
cervical cancer, the future brings hopes of eradicating cervical cancer altogether- A study
publishe d tn The New England Journal of Medicine TnZAOZ revealed promising results after a
trial of an HpV-16, virus-like vaccine was administered to2,392 women. The lindings after one
year indicated "the incidence of persistent HPV-16 infection was 3.8 per 100 woman-years at
risk in the placebo group and 0 per 100 woman-years at risk in the vaccine group (LOOVo
efficacy ; gSVo CI g0 - 100, p < 0.001). All g cases of HPV- 1 6-related cervical intraepithelial
neoplasia occurred among the placebo recipients" (Koutsky, Ault, Wheeler, Brown, Barr,
Alvarez, et al., p. 1645). Another vaccine that would provide immunization from human
papillornavirus types 6, 11, 16 and 18 is currently being researched by Merck Pharmaceuticals.
However, scientists estirnate that it could take as long as 30 years before an immunotherapy
vaccine would be available to completely eradicate cervical cancer (Kirn, 2002).
In sum, it remains imperative that women, especially overweight and obese women,
continue to be routinely screened for cervical cancer with the Pap smear test. In addition, the
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specitic reasons why overweight and obese women are not receiving routine Pap smears need to
be continuously explored and addressed by the medical community.
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APPENDIX B
Table B 1: Percentages of Overweight Minnesotans Grouped by Age
Source: http://apps.nccd.cdc.gov/brfss/Trends/agechart.asp?qkey=1ggg0&state=MN
Table B2: Percentages of Obese Minnesotans Grouped by Age
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APPENDIX C
Percentages of Overweight and Obese Women in Minnesota
Sources: http://apps.nccd.cdc.gov/brfsslTrends/sexchart.asp?qkey=1001O&state=MN
htt[://a[ps.nccd.cdc.gov/brfss/Trends/sexchart.asp?qkey= 10080&state=MN
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APPENDIX E
The Bethesda System 2001
SPECIMEN TYPE: Indicate conventional smear (Pap smear) vs. liquid based vs. other
SPECIMEN ADEQUACY:
r Satisfactory for evaluation (describe presence or absence of endocervical/transformation zone component and any other
quality indicators, e.g., partially obscuring blood, inflammation, etc.)
r Unsatisfactory for evaluation ... (specify reason)
o Specimen rejected/not processed (specify reason)
o Specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality because of
(specify reason)
AUTOMATED REVIEW: If case examined by automated device, specify device and result-
CATEGORIZATION:
o Negative for Intraepithelial Lesion or Malignancy
o Other: (Endometrial cells in a woman 40 years of age)
. Epithelial Cell Abnormality: (specify'squamous'or'glandular' as appropriate)
. Other Malignant Neoplasms
INTERPRETATTON / RESULT:
. NECATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY (when there is no cellular evidence of
neoplasia, state this in the General Categorization above and/or in the Interpretation/Result section of the report,
whether or not there are organisms or other non-neoplastic findings)
O ORGANISMS:
. Trichomonas vaginalis
. Fungal organisms morphologically consistent with Candida spp
. Shift in flora suggestive of bacterial vaginosis
. Bacteria morphologically consistent with Actinomyces spp.
. Cellular changes consistent with Herpes simplex virus
OTHER NON NEOPLASTIC FINDINGS (Optional to report; list not inclusive):
. Reactive cellular changes associated with inflammation (includes typical repair), radiation or
intrauterine contraceptive device (IUD)





ENDOMETIRIAL CELLS in a woman 40 years of age. (specify if 'negative for squamous intraepithelial
lesion)
EPITHELIAL CELL ABNORMALITIES :
"'-l,,#jft 
finmim:-+hiffi f,',','ffi 1;]*;i*ffi]]]f*[f*iuf-]
CIS/CIN 2 and CIN 3, with features suspicious for invasion (if invasion is suspected)
Squamous cell carcinoma
GLANDULAR CELL
. Atypical: endocervical cells (NOS or specify in comments), endometrial cells (NOS or specify in
comments), or glandular cells (NOS or speciff in comments)
. Atypical: endocervical cells in favor of neoplasm or glandular cells in favor of neoplasm
. Endocervical adenocarcinoma in situ
. Adenocarcinoma: endocervical, endometrial or extrauterine not otherwise specitted (NOS)
OTHER MALIGNANT NEOPLASMS: (specify) Source: http://bethesda200 I .cancer.gov/terminology.html
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Height
APPENDIX F
DI RECORD DATA COLLE
(women 18 years and older)
Weight:
Age:_
Gender of Provider: M F
Marital Status: M notM
Smoking Status: YI{
Full Physical Exam within the previous 3 years: Y N
Pap Smear within the previous 3 years: Y N
MEDICAL RECORI} TA COLLECTION




Gender of Provider: M F
Marital Status: M not M
SmokingStatus: Y _N
Full Physical Exam within the previous 3 years: YN
Pap Smear within the previous 3 years: Y N
APPENDIX G
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